TSS:Rfhg 1819.1

Basic information about the TSS

---

TSS ID: rfhg_1819.1 Species: human Chr: chr1		Start: 12617304 End: 12617310 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D2128252,EH38E1319930)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: DQ426869:-33 GeneID: 9249 HGNC/MGI_ID: HGNC:17693 UniProt_ID: Q0QD44 Nearer transcript ids and distances: KJ897985:-38 DQ893006:-38 DQ896252:-38 CU678154:-39 AF061741:-91 AK222593:-92 BC002730:-153 AK310202:-323 AY358093:-328 AK309282:-372 AK312961:-376 BX648476:-421 view more...

Gene_name: dehydrogenase/reductase 3 Gene_symbol: DHRS3 Gene_synonyms: RDH17 Rsdr1 SDR1 SDR16C1 retSDR1 Gene_source: HGNC:17693

TATA-Box annotation

---

Distance to TSS:	-518
Nearest PromoterID:	NM_001319225
Entrez ID:	9249
Nearest Unigene:	Hs.289347
Nearest Refseq:	NM_004753
Nearest Ensembl:	ENSG00000162496
Gene Name:	dehydrogenase/reductase 3
Gene Alias:	DD83.1|RDH17|Rsdr1|SDR1|SDR16C1|retSDR1
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.428571
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@DHRS3 p2@DHRS3 p3@DHRS3 p4@DHRS3 p5@DHRS3 p6@DHRS3 p7@DHRS3 p8@DHRS3 p9@DHRS3
Sample		p1@DHRS3	p2@DHRS3	p3@DHRS3	p4@DHRS3	p5@DHRS3	p6@DHRS3	p7@DHRS3	p8@DHRS3	p9@DHRS3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	0.58	2.53	2.53	0.97	0.39	0.19	2.73	0.39	1.17
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	1.21	3.24	4.05	1.21	0.61	0.00	0.81	0.61	1.01
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	0.58	2.51	1.93	1.16	0.77	0.77	2.70	0.19	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	0.00	1.46	1.04	1.46	0.21	0.42	2.49	0.00	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	1.35	2.02	0.45	0.22	0.22	0.00	1.80	0.22	1.35
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	0.58	2.33	1.74	0.58	0.19	0.39	1.36	0.00	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	0.22	1.53	1.74	0.44	0.00	0.00	0.00	0.00	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	0.24	2.66	1.45	0.48	0.97	0.24	0.48	0.24	1.70
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	0.85	1.28	0.64	0.00	0.43	0.64	1.07	0.21	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	0.00	1.16	1.74	0.58	0.00	0.00	1.74	0.00	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	0.00	1.62	0.81	1.21	0.40	0.00	2.43	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	0.00	0.81	0.81	0.81	0.41	0.41	2.03	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	218.58	122.67	33.04	37.07	12.41	9.03	8.06	26.27	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	201.02	86.90	23.00	24.51	9.47	8.72	10.07	28.87	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	203.75	95.94	28.10	25.69	10.98	6.37	9.88	24.59	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	170.26	104.37	35.46	37.22	9.56	7.80	8.30	22.63	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	205.08	105.05	25.77	31.01	10.92	7.43	10.48	19.66	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	223.98	110.09	29.53	41.34	11.81	10.12	9.70	23.20	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	254.85	76.24	21.33	26.12	8.53	4.80	13.86	23.99	3.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	238.30	106.81	28.58	24.22	10.68	9.03	8.12	31.74	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	211.04	101.71	27.53	20.05	10.96	8.02	8.02	33.01	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	242.88	100.12	30.90	23.30	14.67	10.36	9.32	32.63	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	188.20	85.83	24.82	20.81	15.64	9.57	6.72	23.14	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	163.80	121.09	28.39	31.55	13.59	9.46	8.49	19.41	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	221.36	126.16	28.64	23.74	15.22	11.87	10.84	23.74	5.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	293.72	120.91	23.11	32.60	11.39	6.96	8.23	31.65	2.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	294.51	85.72	25.28	34.07	14.29	5.49	17.58	17.03	3.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	259.80	94.07	25.93	19.10	10.84	13.20	10.37	33.24	4.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	254.56	97.08	20.51	20.51	12.11	9.53	10.01	35.54	3.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	190.74	102.06	28.95	22.44	15.92	10.68	14.12	23.89	3.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	200.34	78.29	21.98	27.84	14.44	6.28	8.58	20.52	4.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	222.15	97.69	24.62	30.67	11.53	9.18	8.99	23.45	3.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	228.12	81.46	24.69	24.69	12.24	4.22	8.02	25.96	3.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	250.87	69.77	24.91	23.26	13.36	7.59	7.75	26.56	5.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	166.05	87.70	24.12	21.13	13.09	6.92	7.67	22.06	3.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	154.83	91.60	22.42	19.55	13.41	8.24	6.71	20.50	4.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	122.83	71.33	17.78	16.35	10.01	5.11	6.74	11.04	6.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	110.62	48.56	18.34	17.93	9.07	5.44	7.05	11.69	3.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	140.18	49.97	18.91	15.67	7.29	6.48	3.24	16.48	4.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	86.90	34.81	11.04	9.36	6.24	3.84	6.00	7.68	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	80.46	41.17	18.11	14.82	6.35	2.82	4.71	9.18	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	93.55	30.30	15.23	8.05	7.76	4.54	4.68	8.49	2.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	55.25	28.89	9.49	6.75	5.27	4.01	3.59	4.85	3.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	61.19	31.47	7.87	9.62	7.52	3.67	4.02	5.42	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	69.27	26.90	10.84	6.63	5.22	4.02	4.22	5.82	3.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	52.58	22.33	10.47	6.75	4.42	3.02	2.33	4.89	3.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	38.62	22.55	9.12	8.64	5.04	0.72	2.40	2.88	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	39.64	12.22	8.64	6.86	2.09	2.09	4.17	6.26	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	39.26	24.18	11.97	7.66	3.35	3.59	3.11	2.87	3.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	51.16	19.21	6.87	7.08	5.66	3.64	2.02	3.64	2.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	48.57	19.06	8.20	6.15	6.97	5.53	1.64	5.74	2.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	57.15	53.37	15.12	8.01	9.56	7.78	4.23	5.11	8.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	6562.33	1958.91	825.54	13.99	13.99	41.98	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	34.78	42.23	17.03	10.65	9.58	8.87	2.48	4.97	9.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	51.36	56.34	16.90	11.60	11.60	9.94	4.64	2.65	10.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	54.53	255.04	125.84	41.11	9.23	5.87	4.19	5.87	5.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	85.42	68.43	28.01	15.15	10.56	7.81	6.89	7.81	7.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	34.03	85.89	20.74	18.47	16.85	12.32	10.05	3.24	15.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	33.40	88.96	22.80	15.74	12.53	8.35	8.99	2.57	13.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	81.41	141.76	62.55	25.78	16.66	11.63	9.43	6.60	8.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	43.01	108.58	26.09	11.28	20.45	16.22	12.69	4.23	19.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	37.01	109.91	30.84	15.14	21.87	7.85	10.09	2.80	18.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	70.06	290.59	121.81	36.62	16.72	5.57	12.74	3.98	7.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	66.25	94.46	33.64	13.93	16.31	15.29	14.61	4.42	11.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	36.39	106.90	28.59	18.85	24.04	12.67	7.15	4.55	15.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	15.62	58.22	22.01	8.87	10.65	8.52	8.87	0.71	11.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	6805.02	2165.97	695.05	32.33	0.00	16.16	0.00	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	2724.63	773.95	213.23	0.00	23.69	23.69	0.00	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	5.85	18.53	4.88	5.36	4.39	3.90	1.46	0.49	5.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	11.90	20.83	4.96	3.47	4.46	2.48	1.98	1.98	3.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	5.16	17.36	8.91	4.69	3.75	1.41	2.81	0.94	7.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	15.90	26.16	7.95	6.29	8.61	9.27	7.62	0.33	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	5.57	29.39	6.81	7.11	8.66	5.88	4.33	0.93	4.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	6.11	25.38	6.42	6.11	5.81	7.03	4.89	0.92	3.67
Adipocyte - breast, donor1	11376-118A8	11.88	16.79	17.11	7.13	2.69	4.28	1.43	0.79	0.16
Adipocyte - breast, donor2	11327-117E4	20.37	21.98	20.53	9.47	3.53	5.94	2.41	2.25	0.64
Adipocyte - omental, donor1	11473-119C6	50.38	48.09	43.89	19.97	14.76	9.16	7.76	3.44	1.27
Adipocyte - omental, donor2	11474-119C7	24.67	7.47	44.10	8.22	3.74	2.24	2.99	2.24	2.24
Adipocyte - omental, donor3	11475-119C8	63.97	19.09	54.93	19.76	8.04	8.04	9.71	9.04	1.34
Adipocyte - perirenal, donor1	11476-119C9	31.90	18.50	62.52	20.42	15.31	7.02	3.19	0.64	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	5.50	13.19	0.00	4.40	2.20	0.00	3.30	1.10	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	5.42	7.23	2.26	1.35	0.45	1.35	2.26	0.90	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	27.11	33.19	8.52	7.82	2.26	6.43	4.87	3.13	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	0.78	1.96	1.96	1.96	0.59	1.37	0.78	0.39	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	3.35	6.43	3.60	2.06	4.63	3.09	2.32	0.77	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	0.84	2.79	2.79	0.84	0.84	1.67	0.28	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	1.18	1.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	46.41	31.61	9.33	8.20	2.33	15.44	9.65	3.38	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	2.58	4.52	1.29	0.97	0.00	1.61	0.65	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	8.53	5.87	6.40	0.53	0.53	0.00	1.60	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	11.69	10.57	3.34	4.45	0.00	3.90	3.90	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	45.75	24.12	12.89	8.32	6.24	14.97	10.40	2.50	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	10.80	12.56	6.28	5.02	1.00	1.76	1.51	0.50	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	19.63	14.73	9.16	3.27	1.31	2.29	2.62	1.31	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	21.62	29.23	7.00	5.78	3.04	5.78	5.48	2.13	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	61.44	29.39	23.20	9.94	8.84	7.07	6.85	7.51	4.42
Alveolar Epithelial Cells, donor2	11590-120G6	20.80	11.83	61.32	9.32	6.10	3.59	5.02	3.23	14.70
Alveolar Epithelial Cells, donor3	11671-122G6	76.67	58.70	45.52	21.56	5.99	1.20	13.18	3.59	7.19
Amniotic Epithelial Cells, donor1	11533-120A3	0.18	1.08	0.36	0.00	0.00	0.36	0.18	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	1.67	1.67	0.00	0.00	0.00	0.00	0.00	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	0.00	0.21	0.21	0.21	0.00	0.00	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	2.17	4.35	2.40	1.03	0.46	0.46	0.46	0.46	0.00
Anulus Pulposus Cell, donor2	11463-119B5	5.39	3.67	3.67	0.98	0.73	2.69	0.24	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	17.97	32.80	17.07	7.64	3.15	3.59	2.25	1.35	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	23.44	22.14	16.50	12.16	4.34	3.91	1.74	1.30	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	17.12	10.70	12.84	4.28	8.56	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	22.72	29.89	17.64	9.57	3.89	5.08	2.39	2.69	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	24.03	39.20	21.50	12.65	5.06	5.06	3.79	2.53	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	14.52	27.06	9.24	13.20	3.30	5.94	3.30	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	20.14	26.64	18.19	7.80	1.95	1.95	1.95	2.27	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	22.82	28.16	20.39	10.19	4.85	2.43	2.43	0.97	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	14.25	22.57	16.03	17.22	4.16	2.38	4.16	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	24.48	27.49	15.82	12.05	3.77	2.64	1.13	1.88	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	25.40	31.93	14.51	7.98	4.35	4.35	2.18	2.90	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	18.81	35.11	17.55	10.03	1.25	2.51	0.00	2.51	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	15.32	9.06	7.41	3.95	1.65	1.48	0.82	1.15	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	23.20	24.57	6.82	16.38	0.00	0.00	1.36	2.73	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	17.64	26.39	12.36	7.99	3.62	6.63	4.22	0.60	1.06
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	21.43	28.40	16.61	6.97	0.54	3.21	1.61	1.07	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	16.82	23.05	16.06	11.34	3.21	2.46	2.08	1.89	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	17.37	27.26	17.11	12.56	3.74	3.47	3.47	0.80	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	13.66	18.53	7.80	12.68	0.00	1.95	0.00	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	15.76	21.06	16.25	6.80	1.99	3.32	2.49	1.99	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	20.41	30.02	16.81	8.41	1.20	4.80	2.40	2.40	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	24.78	0.00	14.16	7.08	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	11.32	17.84	9.43	6.69	1.20	4.29	1.89	1.72	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	20.97	12.58	4.19	8.39	0.00	12.58	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	15.53	24.27	14.08	7.77	2.43	0.97	0.97	1.94	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	14.04	18.97	10.62	4.17	1.52	3.79	2.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	7.27	15.75	6.06	9.69	0.00	4.85	2.42	1.21	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	13.68	29.07	18.24	6.27	3.99	2.28	2.28	1.71	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	12.61	17.32	12.83	8.34	1.71	3.42	1.07	1.71	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	12.13	23.23	8.78	8.26	2.84	3.36	2.58	0.26	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	22.99	28.62	17.83	4.69	2.82	2.35	2.35	1.41	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	18.97	26.05	11.90	14.15	3.86	3.86	3.22	2.25	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	13.56	21.40	11.42	10.70	3.57	3.57	1.43	1.43	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	22.81	24.57	10.53	7.02	1.75	3.51	3.51	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	17.16	26.19	19.87	10.24	3.31	6.62	1.51	1.20	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	24.95	46.33	14.26	26.14	3.56	4.75	5.94	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	25.94	28.48	20.34	9.66	2.54	6.10	2.54	2.54	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	18.08	27.25	14.77	12.99	2.55	5.09	2.29	2.55	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	16.52	22.24	14.61	12.07	3.18	2.54	0.64	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	19.42	27.19	13.38	11.22	3.02	4.75	2.16	0.86	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	15.24	24.98	14.39	9.95	2.96	4.02	1.27	1.48	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	17.40	28.42	13.05	10.44	3.77	6.38	4.35	1.16	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	20.78	27.40	12.28	13.23	2.83	0.94	0.94	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	14.92	22.89	15.60	8.98	3.39	3.56	1.70	0.68	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	20.85	57.91	20.85	13.90	4.63	2.32	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	25.35	2.11	14.79	2.11	0.00	4.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	15.87	20.15	12.86	8.58	1.50	2.79	1.29	3.22	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	19.25	28.88	7.22	9.63	0.60	1.80	1.80	1.20	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	18.95	24.06	10.93	5.83	1.46	5.83	0.00	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	14.48	19.77	9.66	5.75	3.68	2.30	2.53	1.84	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	17.85	12.75	7.65	2.55	5.10	2.55	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	8.14	15.25	7.12	5.59	3.05	4.07	3.31	0.51	1.78
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	9.70	14.04	10.12	6.40	2.27	3.10	2.48	1.86	1.24
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	10.10	20.50	8.87	11.02	2.75	4.28	3.37	0.92	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	14.34	19.12	8.60	3.82	2.87	3.35	0.48	0.48	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	9.53	18.18	10.64	8.65	1.33	4.66	1.55	1.11	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	33.57	12.21	7.63	1.53	4.58	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	8.31	8.86	8.86	1.11	1.11	1.11	0.00	0.00	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	9.80	10.86	7.15	7.68	2.12	1.06	1.06	0.79	1.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	7.27	13.45	5.45	6.18	1.82	2.54	1.45	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	203.51	37.83	43.72	22.97	7.37	15.47	17.93	9.70	1.84
Astrocyte - cerebellum, donor2	11580-120F5	102.70	24.65	39.37	14.21	7.36	8.22	13.52	11.81	1.54
Astrocyte - cerebellum, donor3	11661-122F5	107.60	69.01	48.87	26.43	9.86	9.02	6.29	5.03	2.31
Astrocyte - cerebral cortex, donor1	11235-116D2	96.56	52.98	24.75	17.08	3.83	8.02	9.06	5.93	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	21.03	15.21	9.54	6.47	1.78	3.72	3.07	1.46	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	25.06	16.56	5.82	3.13	1.04	4.47	5.07	1.04	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	0.46	0.69	3.67	0.80	1.03	1.38	0.69	0.11	1.72
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	0.38	1.75	3.01	0.50	1.63	1.00	1.00	0.13	1.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	0.68	1.48	3.64	0.46	0.46	0.80	0.57	0.34	1.48
Basophils, donor1	12241-129G9	0.78	1.83	4.97	1.05	8.89	0.26	0.52	0.00	0.78
Basophils, donor2	12242-129H1	0.00	2.16	3.97	2.89	8.66	0.72	0.36	0.00	0.36
Basophils, donor3	12243-129H2	0.59	1.18	3.23	1.03	3.67	1.18	1.03	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	0.00	0.65	2.80	0.22	0.86	0.22	0.00	0.65	3.45
Bronchial Epithelial Cell, donor2	11591-120G7	2.29	0.91	33.37	1.37	2.74	0.00	0.91	0.00	19.66
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	7.17	0.00	0.00	0.00	0.00	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	1.88	0.00	6.90	0.00	0.00	0.00	0.63	0.00	3.77
Bronchial Epithelial Cell, donor5	11457-119A8	0.00	0.00	1.46	0.00	0.42	0.00	0.00	0.00	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	0.46	0.23	3.45	0.00	0.23	0.23	0.23	0.00	2.30
Bronchial Epithelial Cell, donor7	11769-123I5	0.36	0.00	1.98	0.18	0.18	0.00	0.18	0.00	2.52
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	0.00	0.64	1.28	0.00	0.00	1.28	0.64	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	1.13	12.40	6.76	0.56	4.51	1.13	0.00	0.00	1.13
CD14+ Monocytes, donor2	11305-117B9	0.56	9.28	5.75	2.41	2.60	0.74	1.11	0.00	0.93
CD14+ Monocytes, donor3	11381-118B4	0.44	3.29	5.27	1.76	5.71	2.41	1.10	0.00	1.98
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	8.21	18.96	23.21	11.89	10.76	6.79	4.53	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	6.07	32.22	20.85	12.13	18.57	15.16	6.44	0.38	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	5.92	25.64	16.77	13.81	13.15	13.48	7.89	0.00	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	0.14	1.73	1.30	0.58	0.00	1.01	0.14	0.00	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	0.00	0.60	2.72	1.81	0.00	1.21	0.30	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	0.00	2.61	1.18	0.00	1.42	1.66	0.47	0.00	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	0.17	1.34	1.00	0.50	1.00	0.33	0.33	0.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	0.00	0.55	0.55	0.00	0.00	0.55	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	0.25	1.49	0.74	0.00	0.74	0.50	0.25	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	0.00	0.39	0.98	0.39	1.37	0.39	0.20	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	0.18	0.36	1.25	0.00	0.00	0.36	0.18	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	0.22	0.44	0.44	0.22	0.87	0.65	0.44	0.00	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	0.47	0.70	1.40	0.70	0.47	1.40	0.00	0.00	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	0.00	1.06	0.53	0.53	0.00	1.06	0.00	0.00	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	0.00	3.33	3.33	0.00	0.00	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	0.15	2.23	2.08	1.04	1.04	1.19	0.30	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	0.00	0.80	0.60	1.00	0.60	0.20	0.20	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	0.21	0.62	0.62	0.21	0.42	0.21	0.42	0.00	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	0.46	2.52	4.35	0.92	1.37	0.46	0.23	0.00	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	0.23	1.13	0.23	0.45	0.68	2.49	0.90	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.00	2.18	1.75	0.44	0.00	0.00	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	0.00	1.61	1.08	0.27	0.54	0.81	0.27	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	0.35	2.09	1.40	0.35	0.52	0.52	0.17	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	0.00	0.84	0.42	0.42	0.84	0.84	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.00	1.29	0.92	0.73	0.92	0.00	0.18	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.00	1.06	0.70	0.35	0.35	0.00	0.00	0.35	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	0.00	1.32	0.88	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	0.17	1.22	1.92	0.52	0.52	0.87	0.35	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	0.37	1.12	0.74	0.37	0.00	0.74	0.74	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	0.43	0.65	0.86	0.00	0.43	1.72	0.22	0.00	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	0.82	3.69	2.05	0.00	0.41	0.41	0.41	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	0.00	0.00	0.46	0.23	0.00	0.46	0.46	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.23	0.70	0.46	0.23	0.23	0.93	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	0.00	0.00	0.00	0.00	0.22	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	0.00	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	0.00	0.22	0.00	0.00	0.22	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	0.00	0.47	0.16	0.00	0.16	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	0.00	0.00	0.17	0.52	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	0.22	0.22	0.45	0.00	0.00	0.45	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	0.00	0.82	0.00	0.00	0.82	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	0.00	0.73	1.45	0.00	0.73	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	0.00	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	4.85	6.46	2.02	2.42	5.66	0.81	1.62	0.81	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	2.40	5.99	3.99	1.60	3.99	2.00	2.80	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	0.00	0.00	1.00	0.00	3.01	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	0.00	0.00	3.93	0.00	3.93	0.56	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	2.63	3.01	4.13	1.50	1.88	1.50	1.50	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	1.13	2.48	2.48	1.35	1.13	4.06	1.80	0.68	0.00
CD4+ T Cells, donor1	11225-116C1	0.00	0.36	19.28	1.79	14.28	0.36	1.43	0.00	3.93
CD4+ T Cells, donor2	11306-117C1	0.00	4.90	31.84	3.67	20.82	0.61	0.00	0.00	6.12
CD4+ T Cells, donor3	11382-118B5	0.91	3.35	11.28	1.22	12.50	0.91	1.22	0.00	5.79
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	0.26	0.00	1.53	0.00	0.77	0.26	0.26	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.22	0.45	1.80	0.45	1.12	0.45	0.00	0.00	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.00	1.72	2.30	0.00	1.44	0.00	0.00	0.29	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	1.42	0.47	11.85	0.47	16.12	0.95	0.47	0.00	4.27
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	1.40	0.70	14.05	1.40	11.94	0.00	0.00	0.00	7.73
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	19.78	0.00	3.30	0.00	0.00	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	0.14	1.16	3.90	0.58	3.47	0.29	0.43	0.14	0.87
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	0.34	1.86	3.73	2.03	2.03	0.68	0.68	0.00	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	1.13	1.77	7.74	1.93	3.55	0.64	0.81	0.16	1.13
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.45	0.45	0.45	0.45	1.34	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.00	0.00	0.35	0.00	1.40	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.00	0.00	0.88	0.00	0.44	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	3.37	4.64	18.97	2.11	21.08	0.42	2.11	0.42	7.17
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	3.12	3.53	21.40	4.16	25.35	2.49	1.66	0.42	7.48
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	3.01	5.68	23.39	4.34	13.70	1.67	1.00	0.00	6.35
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	1.63	1.90	22.57	0.00	17.40	0.27	0.82	0.00	9.79
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1.61	2.68	21.44	1.07	21.44	1.07	3.22	0.00	12.86
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1.79	5.38	25.11	0.00	19.73	1.79	0.00	0.00	5.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	0.00	0.74	3.15	0.74	3.34	0.19	0.00	0.00	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	0.00	0.43	2.17	0.00	1.30	0.22	0.00	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	0.00	0.00	0.42	0.21	0.84	0.00	0.00	0.00	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	0.00	0.00	4.04	0.00	7.08	0.00	0.00	0.00	2.53
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.43	0.43	6.07	0.43	4.77	0.00	0.00	0.00	3.90
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	0.00	2.18	4.36	0.44	10.46	0.00	0.44	0.00	2.18
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	1.48	0.99	9.90	0.99	11.38	0.49	0.49	0.49	4.45
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.00	0.00	10.16	0.92	13.85	0.00	0.92	0.00	4.62
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	2.79	1.40	16.75	1.40	8.37	0.00	0.00	1.40	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	0.83	0.55	6.92	0.28	4.98	0.00	0.00	0.00	2.49
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	0.98	0.00	9.82	0.74	7.12	0.49	0.98	0.00	4.42
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	0.00	1.54	9.24	1.54	9.24	0.00	1.54	1.54	6.16
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	1.43	1.43	13.97	1.43	14.32	0.00	0.00	0.00	6.80
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	0.00	1.38	5.54	2.77	12.46	0.00	0.00	0.00	4.15
CD8+ T Cells, donor1	11226-116C2	2.29	0.98	14.08	1.31	9.82	0.33	0.98	0.00	0.98
CD8+ T Cells, donor2	11307-117C2	0.00	1.50	10.89	1.88	10.51	1.13	1.13	0.38	2.25
CD8+ T Cells, donor3	11383-118B6	1.77	2.27	19.95	1.77	22.22	1.26	1.01	0.00	7.07
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	1.84	2.06	0.69	0.46	0.00	1.61	0.69	0.46	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	1.44	3.12	0.48	0.72	0.24	1.20	0.72	0.24	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	1.92	1.37	1.09	0.55	0.00	0.82	1.64	1.09	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	1.80	4.20	1.50	1.20	0.30	0.60	0.90	0.60	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	3.12	4.80	0.96	1.44	0.24	1.20	0.72	0.48	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	2.73	5.00	1.82	1.36	0.00	1.14	1.59	0.68	1.36
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	2.17	3.91	2.17	0.43	0.00	0.43	1.09	0.22	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	3.95	3.16	2.11	0.79	0.00	0.79	1.58	0.26	1.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	2.58	3.28	1.64	0.23	0.00	0.94	0.70	0.47	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	2.42	3.32	2.72	0.91	0.00	0.91	1.51	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	4.36	3.78	2.32	0.87	0.00	0.87	0.87	0.87	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	2.13	2.66	0.27	0.80	0.00	0.80	0.80	1.07	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	2.63	6.13	4.82	3.06	0.88	1.75	1.31	0.88	3.50
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	2.73	5.01	3.19	0.91	0.00	1.82	0.46	0.91	2.73
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	2.24	6.71	2.24	0.75	0.00	0.75	0.00	0.00	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	2.88	6.12	0.72	0.36	0.00	1.44	1.08	1.44	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	2.01	4.32	1.73	1.44	0.00	0.29	0.86	1.15	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	1.89	4.01	1.41	1.41	0.24	1.65	0.47	0.47	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	1.90	3.17	1.27	0.00	0.00	0.63	0.32	1.27	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	2.77	5.23	2.15	0.62	0.00	0.00	1.85	0.31	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	1.60	2.24	1.92	0.64	0.00	0.96	0.64	0.96	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	2.68	4.59	1.91	1.53	0.00	0.76	1.91	0.38	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	2.76	4.73	1.18	0.00	0.00	0.39	1.18	0.00	1.97
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	1.51	5.29	0.76	1.51	0.00	0.76	0.76	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	2.41	5.62	8.03	2.41	0.00	1.61	0.00	1.61	6.42
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	2.80	4.90	4.90	4.20	1.40	1.40	0.70	0.00	9.09
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	3.01	5.01	5.01	2.00	1.00	0.00	2.00	3.01	7.01
Cardiac Myocyte, donor1	11525-119I4	7.31	7.31	1.83	0.00	5.48	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	172.44	123.52	107.71	47.43	14.33	6.42	10.87	25.20	1.48
Cardiac Myocyte, donor3	11686-122I3	104.29	91.55	64.09	21.99	19.15	12.73	8.94	11.26	1.16
Chondrocyte - de diff, donor1	11261-116G1	9.71	11.79	9.71	12.13	2.08	5.89	5.89	0.00	0.69
Chondrocyte - de diff, donor2	11338-117F6	7.11	7.46	4.26	2.84	1.42	3.91	1.07	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	10.58	14.79	7.96	3.75	1.82	3.19	1.71	0.57	0.34
Chondrocyte - re diff, donor2	11339-117F7	5.37	0.90	0.00	0.00	0.00	0.90	3.58	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	7.28	4.45	5.66	1.21	4.04	3.64	2.02	0.81	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	87.22	48.20	25.94	11.36	7.00	9.98	6.43	4.93	1.03
Ciliary Epithelial Cells, donor2	11323-117D9	61.14	36.13	36.13	15.60	7.70	6.63	2.57	3.85	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	103.37	58.50	33.89	13.89	11.42	11.24	8.14	11.33	1.24
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	7.98	8.62	10.73	3.03	5.96	4.59	0.92	1.19	1.10
Corneal Epithelial Cells, donor1	11526-119I5	0.44	0.66	5.49	0.00	0.88	0.00	0.22	0.00	5.27
Corneal Epithelial Cells, donor2	11606-120I4	1.14	1.14	4.55	1.14	1.14	0.00	2.28	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	0.00	0.77	3.58	0.26	0.77	0.00	0.51	0.00	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	1.49	4.46	2.81	1.32	0.83	2.48	0.83	0.00	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	1.26	2.84	5.68	0.00	0.63	0.95	0.63	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	1.73	4.21	2.70	1.19	2.48	2.70	1.51	0.00	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	0.00	0.00	0.00	0.00	0.34	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	0.00	0.00	0.65	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	0.00	0.00	0.48	0.00	0.00	0.48	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	1.33	2.00	2.00	0.33	0.17	0.83	0.17	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	4.11	1.76	1.76	0.00	1.17	1.17	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	3.11	2.55	0.85	0.57	0.85	0.85	0.85	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	8.65	2.36	1.18	0.79	0.79	3.15	1.97	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	8.73	4.07	2.62	1.16	1.16	3.49	2.04	0.58	0.00
Endothelial Cells - Artery, donor2	11341-117F9	2.82	8.47	5.41	2.12	0.47	0.94	0.71	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	2.98	2.45	2.10	1.05	0.18	1.40	0.88	0.35	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	10.42	11.08	6.65	3.55	2.22	1.99	3.32	0.89	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	11.26	9.13	3.96	1.22	2.74	4.26	1.52	1.52	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	9.02	3.66	3.95	2.26	2.26	3.66	3.38	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	10.99	10.10	10.10	5.05	1.49	2.38	1.49	0.89	3.27
Endothelial Cells - Microvascular, donor2	11342-117G1	11.45	9.37	6.77	4.69	0.52	2.60	2.60	0.52	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	6.10	10.78	5.67	1.70	1.56	3.69	1.56	0.71	1.42
Endothelial Cells - Thoracic, donor1	11266-116G6	2.00	0.80	2.00	0.40	0.40	2.00	1.60	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	8.91	15.20	4.72	2.10	1.57	1.05	1.57	0.00	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	6.46	8.08	4.72	2.48	0.50	2.86	2.36	0.99	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	5.65	5.65	2.17	1.09	0.87	2.39	1.09	0.43	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	8.30	5.62	2.08	1.47	0.85	3.30	2.08	0.98	0.00
Endothelial Cells - Vein, donor1	11267-116G7	6.83	0.00	1.14	2.28	0.00	0.00	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	6.99	0.70	0.00	0.00	0.00	3.49	1.40	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	6.75	4.08	3.14	0.94	0.16	1.73	0.79	0.79	0.16
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	0.00	1.65	0.00	0.00	1.65	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	7.13	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	0.49	0.49	1.47	0.00	0.49	0.49	0.00	0.00	1.47
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	0.00	12.48	0.00	0.00	0.00	0.00	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	3.28	12.73	5.75	4.52	2.05	3.69	1.23	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	22.34	26.82	7.34	7.45	8.65	2.96	3.50	1.53	1.97
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	29.47	31.63	5.20	6.72	1.52	2.93	2.49	1.84	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	5.46	7.64	7.52	1.82	3.15	2.55	0.97	0.36	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	23.06	12.83	12.96	6.55	8.46	3.00	2.59	1.64	1.50
Fibroblast - Aortic Adventitial, donor2	11326-117E3	9.91	12.87	11.39	6.43	4.54	3.48	1.37	1.37	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	30.04	8.17	35.83	6.85	11.86	7.64	8.96	3.43	2.37
Fibroblast - Aortic Adventitial, donor3	11401-118D6	30.89	31.56	22.92	7.31	7.64	5.98	5.32	2.66	1.66
Fibroblast - Cardiac, donor1	11268-116G8	10.89	6.80	6.35	5.44	5.90	1.36	2.27	0.91	0.45
Fibroblast - Cardiac, donor2	11345-117G4	43.96	34.87	49.27	12.89	12.89	14.40	12.89	0.76	3.03
Fibroblast - Cardiac, donor3	11417-118F4	7.57	8.83	5.84	1.26	1.73	1.58	0.95	0.00	0.63
Fibroblast - Cardiac, donor4	11452-119A3	1.82	2.73	0.30	0.00	0.30	0.91	0.30	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	3.30	3.81	4.31	1.52	1.27	2.41	2.41	0.63	0.00
Fibroblast - Cardiac, donor6	11460-119B2	3.64	5.31	4.24	2.43	0.91	1.06	0.91	0.30	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	0.40	0.27	1.07	0.27	0.13	1.07	0.54	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	0.43	0.86	1.29	0.00	0.00	1.29	0.43	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	86.42	98.14	57.13	27.83	7.32	19.04	24.90	14.65	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	0.23	1.61	0.23	0.00	0.23	0.46	1.15	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	7.97	6.44	2.54	2.54	1.53	4.07	2.20	0.51	0.17
Fibroblast - Dermal, donor1	11269-116G9	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	2.83	1.42	0.00	0.47	0.00	0.47	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	0.00	0.12	0.24	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor4	11450-119A1	0.00	0.11	0.00	0.23	0.00	0.00	0.11	0.11	0.00
Fibroblast - Dermal, donor5	11454-119A5	0.17	0.52	0.00	0.00	0.00	0.17	0.17	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	0.00	0.00	0.00	0.00	0.00	0.00	0.16	0.00	0.00
Fibroblast - Gingival, donor1	11237-116D4	0.21	0.00	0.00	0.00	0.00	0.21	0.00	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	8.91	5.24	3.14	1.31	1.31	3.14	2.10	0.52	0.26
Fibroblast - Gingival, donor2	11318-117D4	0.13	0.26	0.26	0.00	0.00	0.00	0.00	0.13	0.00
Fibroblast - Gingival, donor3	11394-118C8	0.48	0.87	0.10	0.29	0.00	0.77	0.29	0.00	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	3.12	7.27	4.16	3.12	0.00	2.08	1.04	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	4.93	12.69	5.29	3.70	0.00	3.88	1.23	0.35	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	6.24	3.43	2.03	2.03	0.31	0.94	0.47	0.62	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	1.22	0.27	0.68	0.14	0.00	0.14	0.27	0.00	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	2.82	0.00	0.00	0.35	0.35	1.76	1.06	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	7.02	3.95	0.88	1.46	0.29	1.32	0.58	0.73	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	11.04	7.77	3.27	2.18	0.82	2.45	1.91	0.68	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	1.10	1.32	0.44	0.66	0.22	1.10	0.44	0.33	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	8.95	5.28	2.93	2.93	0.73	5.28	3.08	0.44	0.15
Fibroblast - Lung, donor1	11270-116H1	2.72	2.72	2.72	1.36	0.00	6.80	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	0.00	0.21	0.21	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	3.33	0.83	0.00	0.83	0.00	1.67	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	6.99	1.40	1.40	0.00	0.00	0.00	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.64	5.04	3.92	3.36	2.80	1.12	1.96	0.28	0.56
Fibroblast - Mammary, donor1	11540-120B1	2.44	1.62	0.81	0.00	0.00	0.41	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	0.00	0.00	0.00	0.00	11.91	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	0.00	0.00	0.00	0.19	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	0.15	0.15	0.30	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	0.00	0.00	0.31	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	3.05	2.29	1.53	0.76	0.38	0.76	1.14	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	12.15	22.68	14.31	8.91	1.89	1.89	2.16	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	6.84	15.66	4.75	1.74	1.04	7.77	3.13	0.70	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	17.35	19.12	9.84	4.31	7.52	3.09	2.43	1.22	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	5.89	3.45	1.02	0.81	0.20	0.81	0.61	0.81	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	0.00	0.67	0.00	0.67	0.00	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	0.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	6.15	1.39	4.76	1.79	1.98	1.59	3.18	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	25.40	12.97	9.95	3.73	3.20	6.93	5.86	0.89	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	9.46	9.46	4.73	3.15	2.37	5.32	3.74	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	3.91	1.81	3.91	0.60	1.50	1.81	0.60	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	10.26	6.26	5.61	3.24	0.86	5.51	3.99	1.19	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	12.65	4.30	11.39	4.05	5.82	2.02	5.31	1.01	0.00
Fibroblast - skin normal, donor1	11553-120C5	14.77	9.19	5.41	3.77	2.13	5.58	2.46	0.66	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	5.81	9.82	7.22	4.21	4.21	4.81	1.80	1.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	11.85	6.53	6.33	3.01	1.91	4.22	3.32	0.70	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	6.04	1.81	5.14	1.81	3.02	3.32	4.84	0.91	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	18.56	13.34	8.86	6.79	3.73	7.54	5.22	0.58	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	82.23	17.10	25.47	12.65	2.91	11.97	9.74	4.96	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	4.60	1.64	4.60	1.64	0.33	0.99	2.30	1.31	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	2.77	0.96	1.81	0.96	0.32	1.28	0.85	0.43	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	1.69	2.36	1.35	0.84	0.67	0.67	0.84	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	23.37	34.34	6.43	4.39	4.55	3.92	3.61	1.73	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	155.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	3.49	2.61	4.36	0.87	7.84	0.87	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	1.04	0.69	3.47	0.35	1.56	0.35	0.35	0.00	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	0.00	0.00	0.78	0.00	0.00	0.00	0.00	0.00	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	1.53	2.30	4.60	0.77	1.53	0.51	0.00	0.00	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	3.06	18.37	6.89	3.06	2.30	5.36	13.01	2.30	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	4.47	13.40	7.66	3.19	2.55	5.74	6.38	1.91	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	5.13	18.83	10.84	10.84	0.57	11.98	11.70	0.57	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	1.65	10.20	5.52	5.24	1.93	4.96	4.41	1.10	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	1.60	10.05	3.65	3.65	73.52	23.29	50.23	0.23	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	3.37	16.25	5.75	6.14	8.92	12.48	11.69	0.00	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	1.85	9.25	4.49	5.55	12.95	11.90	14.27	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	0.65	3.26	1.96	2.94	6.20	4.57	5.87	0.33	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	3.10	29.63	8.40	6.19	1.77	14.59	7.08	1.33	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	5.51	8.20	4.10	2.26	1.27	4.52	5.79	0.99	1.41
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	2.83	3.69	1.35	0.62	0.99	1.72	1.60	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	5.10	10.48	4.03	2.42	0.00	4.57	5.37	1.07	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	1.36	0.62	0.74	0.50	0.12	0.25	0.87	0.25	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	1.80	1.11	1.38	0.42	0.14	1.25	1.25	0.28	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	1.02	3.25	4.07	0.81	0.81	0.81	0.61	0.20	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	2.74	3.19	2.97	1.37	0.68	0.68	1.83	0.46	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	1.62	1.49	0.62	0.50	0.50	0.62	0.12	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	0.44	1.75	1.09	1.31	1.09	0.66	1.75	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	2.07	4.43	1.77	2.66	0.89	0.59	2.07	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	1.75	1.43	1.27	0.48	0.64	0.64	0.16	0.16	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	1.79	2.23	1.79	0.67	0.22	0.22	0.89	0.00	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	0.40	2.22	1.01	1.21	0.40	0.81	1.21	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	1.70	1.53	0.68	0.17	0.00	0.34	0.51	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	2.31	2.66	1.86	0.71	0.98	0.27	0.71	0.18	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	1.46	2.08	0.73	0.42	0.42	0.62	0.52	0.00	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	0.68	1.37	0.34	0.17	0.34	0.17	0.68	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	1.66	0.55	0.77	0.22	0.11	0.77	0.89	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	1.08	2.41	2.16	0.58	0.50	0.42	0.33	0.08	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	2.25	1.63	1.02	0.20	1.43	0.41	1.23	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	1.65	1.44	0.41	0.83	0.41	0.41	0.83	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	0.81	0.69	0.35	0.23	0.00	0.81	0.81	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	0.17	0.67	1.00	0.00	0.00	0.00	0.00	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	0.66	1.32	0.88	0.44	0.00	0.22	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	0.86	0.25	0.25	0.37	0.25	0.74	0.12	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	1.13	1.62	1.30	0.32	0.65	0.49	0.81	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	0.00	1.28	0.96	0.32	0.00	0.32	0.64	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	0.57	0.28	0.47	0.19	0.19	0.38	0.09	0.09	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	0.16	0.95	0.16	0.32	0.16	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	0.91	0.91	0.00	0.61	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	1.05	0.73	0.42	0.63	0.21	0.42	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	0.44	1.32	0.88	0.66	0.22	0.00	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	0.28	0.84	0.56	0.84	0.28	0.00	0.56	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	0.37	0.46	0.09	0.09	0.00	0.00	0.09	0.00	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	0.53	0.53	0.00	0.27	0.00	0.27	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	0.61	1.68	0.77	0.92	0.00	0.15	0.46	0.31	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	0.13	0.39	0.39	0.26	0.13	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	0.00	0.00	0.27	0.00	0.00	0.54	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	0.18	0.37	0.00	0.18	0.00	0.18	0.00	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	0.44	0.66	0.88	0.00	0.00	0.00	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	0.13	0.00	0.13	0.13	0.13	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	0.20	0.40	0.40	0.20	0.00	0.00	0.00	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	0.25	2.03	0.51	0.25	0.25	0.25	0.76	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	7.96	7.56	6.17	1.59	0.20	7.17	11.15	1.99	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	6.93	6.78	3.24	1.08	0.77	4.31	3.24	0.77	0.92
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	10.64	9.00	5.93	2.86	0.61	8.59	9.82	2.05	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	9.07	15.33	5.01	2.50	0.31	5.95	6.26	0.94	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	7.35	12.15	5.37	3.39	1.13	3.67	6.50	1.13	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	9.22	19.83	7.38	4.61	0.00	2.77	10.15	1.84	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	2.47	4.95	2.47	0.00	0.00	0.00	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	6.96	8.90	1.93	1.55	0.77	0.39	0.77	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	8.02	20.86	6.42	4.81	0.00	0.00	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	5.22	8.69	1.74	0.00	1.74	0.00	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	3.91	5.21	1.63	0.00	0.33	0.33	0.33	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	4.94	7.41	2.47	2.47	0.00	1.24	1.24	0.41	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	0.00	16.66	6.66	3.33	6.66	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	3.08	4.75	4.47	0.56	0.28	0.56	0.56	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	1.63	5.56	3.27	1.96	0.00	0.00	0.98	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	3.36	7.55	5.87	1.68	0.84	0.00	0.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	2.23	6.36	3.18	0.64	0.00	0.95	1.27	0.00	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	1.70	8.15	2.72	0.68	1.02	1.36	0.34	1.02	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	2.09	4.18	4.18	2.09	2.09	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	4.01	9.74	4.01	1.72	1.72	2.29	1.15	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	5.33	7.99	5.03	2.96	0.89	0.30	0.00	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	3.39	22.02	3.39	1.69	0.00	1.69	1.69	1.69	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	5.38	6.63	0.83	3.31	0.83	0.41	0.83	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	6.90	13.81	3.22	3.68	0.69	2.30	0.92	0.92	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	0.00	10.54	0.00	10.54	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	2.31	9.23	4.23	1.15	1.15	0.38	1.15	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	4.89	10.43	2.93	4.24	0.65	1.63	1.30	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	2.68	6.69	0.67	1.34	2.01	1.34	2.01	0.67	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	3.47	12.71	5.01	1.54	0.39	2.70	1.93	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	3.08	6.16	4.79	1.71	0.34	0.68	2.40	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	0.00	29.82	2.48	0.00	0.00	0.00	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	5.19	11.80	7.55	5.19	1.89	3.77	0.94	1.42	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	3.02	12.07	3.02	5.43	3.02	1.21	1.81	1.81	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	3.56	4.58	2.03	1.02	0.51	0.00	4.58	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	1.60	14.36	4.39	1.99	1.20	1.20	1.99	0.80	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	2.96	7.89	1.48	4.44	0.00	0.49	1.97	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	2.36	10.62	10.62	5.90	2.36	0.00	0.00	1.18	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	4.08	14.00	5.25	4.08	0.58	0.58	2.92	0.00	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	2.63	9.66	7.90	3.07	0.88	0.00	2.19	0.00	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	0.85	14.41	2.54	2.54	0.85	0.85	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	1.79	7.16	2.98	1.79	1.19	0.60	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	3.88	9.22	1.94	1.94	0.97	0.49	1.46	0.97	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	7.99	3.42	1.14	1.14	1.14	0.00	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	0.83	2.49	2.91	1.66	0.00	1.25	0.83	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	1.12	0.00	0.00	0.00	0.00	1.12	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	14.59	34.25	12.37	9.51	3.81	9.20	3.49	3.81	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	27.15	33.42	15.46	5.85	2.09	2.09	1.67	2.09	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	0.70	3.60	2.44	1.28	1.51	0.23	0.58	0.46	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	1.01	2.53	2.36	1.18	1.69	1.52	1.01	0.17	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	0.23	2.50	0.91	0.68	0.46	0.46	0.68	0.23	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	0.66	2.84	1.64	0.55	0.77	0.77	0.77	0.11	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	0.64	3.44	1.93	1.29	0.86	1.07	0.64	0.43	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	0.43	1.72	1.51	1.29	0.65	1.29	0.43	0.22	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	0.75	4.86	3.11	1.25	2.24	1.12	0.75	0.25	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	0.34	2.57	3.26	1.89	0.86	1.89	1.20	0.69	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	0.00	1.28	1.92	0.32	0.64	0.32	1.28	0.32	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	6.16	5.04	6.72	0.00	0.56	3.92	6.72	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	5.63	7.79	3.03	0.87	0.43	4.33	2.60	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	2.64	29.08	2.64	2.64	2.64	7.93	2.64	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	35.98	20.11	11.29	5.29	4.94	6.35	9.88	4.59	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	14.53	16.71	11.62	6.54	2.18	4.36	3.63	1.45	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	47.56	75.53	31.47	16.61	12.59	19.06	9.97	6.12	1.05
Hepatocyte, donor1	11523-119I2	26.63	70.21	139.22	24.21	47.21	9.68	6.05	3.63	16.95
Hepatocyte, donor2	11603-120I1	28.01	57.10	137.90	43.09	43.09	9.70	9.70	2.15	6.46
Hepatocyte, donor3	11684-122I1	14.11	33.74	67.49	11.66	50.31	13.50	4.29	1.23	9.20
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	0.00	0.65	0.65	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	6.99	7.34	15.56	1.92	7.34	0.52	0.87	0.35	2.10
Iris Pigment Epithelial Cells, donor1	11530-119I9	89.73	59.68	30.87	18.52	10.02	7.82	5.63	10.02	1.51
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	44.57	12.74	6.37	9.55	25.47	22.29	6.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	6.68	13.35	0.00	6.68	6.68	33.38	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	108.33	54.17	27.08	0.00	27.08	81.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	20.77	47.07	20.77	6.92	5.54	22.15	33.23	6.92	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	7.51	7.51	2.50	0.00	2.50	5.01	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	106.81	0.00	11.87	11.87	71.21	11.87	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	28.19	7.69	5.13	5.13	20.50	43.57	2.56	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	13.71	9.14	0.00	0.00	0.00	9.14	9.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	19.49	40.61	17.87	6.50	6.50	17.87	16.24	11.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	26.68	46.68	13.34	5.00	1.67	18.34	20.01	3.33	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	25.41	0.00	0.00	0.00	3.63	21.78	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	26.47	21.18	25.15	3.97	7.94	5.29	11.91	5.29	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	15.52	45.45	7.76	6.65	2.22	18.85	18.85	2.22	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	20.95	10.48	0.00	5.24	5.24	36.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	16.38	29.60	11.97	6.30	3.15	18.27	15.12	3.78	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	20.11	30.93	15.47	7.73	9.28	13.92	35.57	6.19	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	14.63	0.00	0.00	43.90	58.54	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	27.78	28.43	16.80	4.52	2.58	14.86	24.55	5.81	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	22.54	40.25	9.66	3.22	6.44	22.54	35.42	3.22	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	0.00	11.95	0.00	47.79	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	30.97	30.97	17.11	0.81	1.63	13.85	17.93	3.26	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	19.73	9.66	4.62	1.68	2.94	6.30	5.46	2.94	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	86.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	18.48	34.56	8.84	8.04	4.82	8.04	20.09	4.82	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	7.39	32.31	15.70	10.16	4.62	15.70	10.16	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	15.08	0.00	0.00	0.00	0.00	75.40	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	12.27	26.43	7.55	4.25	1.89	7.08	10.38	2.36	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	14.51	45.35	16.33	8.16	1.81	7.26	9.98	1.81	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	58.97	14.74	0.00	29.48	14.74	88.45	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	15.07	18.29	10.76	4.30	1.08	5.38	8.61	2.15	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	16.52	26.68	12.70	3.81	5.08	6.35	19.06	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	49.29	0.00	0.00	0.00	0.00	65.72	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	19.77	17.86	9.57	4.46	3.19	10.84	14.03	2.55	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	16.40	30.99	10.94	5.47	0.00	9.11	12.76	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	63.22	0.00	0.00	0.00	15.80	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	27.85	19.99	4.28	2.86	4.28	12.85	14.28	3.57	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	16.59	23.23	6.64	3.32	3.32	19.91	29.86	3.32	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	41.70	0.00	20.85	0.00	0.00	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	12.04	25.31	8.95	3.09	3.09	6.48	8.95	2.16	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	29.85	49.17	5.27	5.27	3.51	22.83	26.34	3.51	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	6.29	3.14	6.29	6.29	6.29	6.29	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	24.34	18.78	11.82	1.39	2.78	8.34	14.60	4.87	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	19.92	26.56	17.70	2.21	0.00	17.70	13.28	6.64	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	22.69	16.21	3.24	0.00	6.48	6.48	16.21	9.73	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	14.82	13.08	7.85	3.49	2.62	9.59	27.90	1.74	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	20.25	9.00	2.25	6.75	11.25	22.50	2.25	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	20.91	0.00	0.00	6.97	6.97	31.36	3.48	6.97
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	10.67	12.80	4.27	3.20	2.13	9.60	16.00	3.20	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	20.78	34.64	16.63	5.54	4.16	15.24	20.78	4.16	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	2.85	11.40	2.85	2.85	2.85	19.95	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	21.17	32.21	12.89	4.60	3.68	11.97	12.89	3.68	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	12.10	3.03	3.03	0.00	6.05	42.35	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	31.04	6.21	0.00	0.00	6.21	24.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	3.17	15.86	9.52	1.06	1.06	6.34	10.57	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	0.08	0.49	0.41	0.16	0.08	0.08	0.00	0.08	0.16
Keratinocyte - epidermal, donor2	11349-117G8	0.00	0.00	0.59	0.00	0.00	0.00	0.00	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	0.28	0.57	1.14	0.47	0.57	0.28	0.38	0.28	0.66
Keratinocyte - oral, donor1	11251-116E9	0.11	0.45	1.36	0.00	0.11	0.11	0.00	0.00	2.27
Keratocytes, donor1	11527-119I6	0.00	1.03	0.34	0.34	0.00	0.69	0.69	0.00	0.00
Keratocytes, donor2	11607-120I5	0.00	0.00	1.17	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	0.40	0.99	0.40	0.20	0.00	0.20	0.00	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	4.40	6.59	2.20	0.00	2.20	0.00	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	61.49	87.38	74.43	19.42	4.31	3.24	5.39	6.47	0.00
Lens Epithelial Cells, donor2	11609-120I7	48.21	24.91	11.42	6.80	1.73	5.07	3.34	2.77	0.46
Lens Epithelial Cells, donor3	11690-122I7	120.39	43.69	44.70	8.58	29.87	7.87	7.16	7.77	3.94
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	6.64	11.38	8.77	3.91	2.02	4.62	1.78	0.47	1.90
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	1.95	4.47	4.19	3.91	0.56	1.12	0.00	0.00	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	2.52	9.76	12.75	3.15	1.26	1.57	0.63	0.00	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.91	10.22	12.91	5.38	0.54	1.08	0.00	0.00	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	0.32	1.58	4.73	0.63	0.32	1.26	0.95	0.00	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	2.70	7.55	7.87	2.37	1.08	1.29	0.43	0.22	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	4.92	10.26	8.62	4.10	1.23	2.05	0.41	0.41	4.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	1.01	5.81	5.31	2.28	0.25	1.26	1.26	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	3.66	9.29	9.43	5.21	1.83	1.69	0.56	0.00	1.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	2.77	8.70	6.33	1.98	1.98	2.77	1.58	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	0.97	2.13	4.46	1.94	0.39	0.19	0.19	0.00	1.36
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	3.15	8.70	13.33	3.52	1.67	1.67	1.30	0.00	0.93
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	6.62	8.71	8.71	3.14	1.05	1.39	1.05	0.35	1.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	1.43	3.58	2.62	2.15	0.72	0.72	0.48	0.00	0.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	2.75	10.16	10.30	5.36	1.10	2.47	0.82	0.41	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	2.46	7.08	8.62	3.08	1.85	1.85	0.31	0.31	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	1.25	2.81	3.43	1.25	0.94	0.94	0.31	0.00	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	2.74	9.33	10.25	4.76	1.83	1.28	0.73	0.18	2.20
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	3.62	8.23	8.56	5.27	1.65	1.65	0.99	0.00	1.32
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	0.88	4.98	7.03	2.34	0.59	1.46	1.46	0.00	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	2.24	9.21	13.94	4.48	1.74	1.49	0.50	0.25	2.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	2.91	4.36	4.85	1.45	0.97	4.36	0.00	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	1.62	3.23	2.96	2.96	0.54	1.62	1.08	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	2.72	10.75	10.90	4.24	1.82	1.67	1.36	0.15	1.36
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	3.11	6.74	7.26	3.11	2.59	1.56	1.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	0.42	3.35	1.88	1.68	0.42	1.26	0.00	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	3.76	7.97	9.47	3.16	1.95	2.71	0.75	0.45	1.05
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	2.75	9.63	11.01	5.50	2.06	2.75	0.69	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	0.56	1.69	2.63	1.13	0.56	0.38	0.00	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	3.18	8.16	7.42	4.24	1.91	0.95	0.85	0.21	1.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	2.42	8.24	6.30	2.42	1.45	2.42	1.45	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	0.99	2.32	3.31	2.32	0.33	0.33	0.33	0.00	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	2.60	12.64	11.65	4.71	1.73	1.86	0.74	0.25	1.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	5.92	9.26	10.37	5.55	2.22	4.07	1.11	1.11	1.85
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	0.49	2.22	3.21	1.24	0.25	0.49	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	3.85	9.07	11.41	3.85	2.06	2.06	1.65	0.41	2.06
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	5.47	7.40	7.08	3.54	1.61	1.93	1.93	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	0.61	2.13	2.43	0.91	0.61	0.91	1.22	0.00	1.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	2.38	8.12	9.80	2.38	0.84	1.54	0.70	0.14	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	3.91	8.89	8.53	2.84	2.13	1.78	0.71	0.00	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	0.00	0.97	2.91	0.97	0.48	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4.98	7.47	12.60	6.38	1.56	2.18	0.47	0.31	1.87
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	4.30	4.30	7.52	1.79	1.07	1.43	1.43	0.72	2.15
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	0.65	2.94	3.27	1.31	0.65	0.33	0.00	0.00	1.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	1.41	9.89	11.77	4.00	0.47	0.94	0.47	0.00	2.59
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	4.08	11.39	5.45	2.72	2.60	4.58	1.86	0.37	1.36
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	0.77	3.59	2.31	1.79	1.02	1.02	0.51	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	2.09	6.56	7.46	2.69	2.69	1.79	0.30	0.30	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	1.53	0.77	0.00	0.77	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	0.00	0.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	0.00	0.85	0.00	0.00	0.42	0.00	0.00	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	0.00	2.11	0.70	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	0.00	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	0.52	0.52	0.52	1.03	0.00	0.00	0.00	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	0.23	0.45	0.90	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	0.29	0.29	0.58	0.00	0.29	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	0.00	0.45	0.45	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	0.27	0.68	0.41	0.00	0.00	0.14	0.00	0.00	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	0.00	1.54	1.03	0.51	0.51	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	0.00	0.71	0.35	0.35	0.00	0.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	0.67	0.00	0.00	0.00	0.00	0.00	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	0.51	1.02	0.51	0.00	0.00	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	0.27	0.80	0.00	0.00	0.53	0.27	0.00	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	0.19	0.94	0.38	0.38	0.00	0.57	0.00	0.00	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	0.61	0.00	0.61	0.00	0.61	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	0.00	0.00	0.82	0.82	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	0.62	0.00	0.42	0.00	0.21	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	0.00	0.56	0.56	0.28	0.00	0.00	0.28	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	1.03	1.03	1.03	0.00	0.00	1.03	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	0.00	0.87	0.58	0.00	0.29	0.00	0.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	0.00	0.30	0.90	0.30	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	0.00	0.55	0.00	0.00	0.00	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	0.00	0.71	1.41	0.00	0.71	0.71	0.71	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	0.74	0.74	0.74	0.37	0.37	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	0.00	1.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	0.00	1.54	0.77	0.38	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	0.00	0.57	0.57	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	0.00	0.45	0.00	0.00	0.90	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	0.00	0.00	0.00	0.00	0.00	0.00	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	0.00	0.00	0.00	0.00	0.00	0.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	0.00	0.37	1.11	0.37	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	0.00	0.43	0.00	0.00	0.43	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	0.00	0.00	0.00	0.33	0.00	0.00	0.00	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	0.00	1.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	0.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	0.00	0.69	0.34	0.00	0.00	0.00	0.69	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	0.00	0.00	1.07	0.00	0.54	0.00	0.00	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	0.00	0.00	0.67	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	0.00	0.37	0.00	0.00	0.00	0.37	1.85	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	2.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	0.00	0.00	1.06	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	0.40	0.40	1.20	0.00	0.80	0.80	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	0.73	0.73	0.00	0.73	0.73	0.00	0.00	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	0.00	2.30	0.77	0.00	0.77	0.00	0.00	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	0.00	0.00	0.49	0.99	0.49	0.49	0.49	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	0.00	0.00	0.94	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	0.50	1.01	0.50	0.00	0.50	1.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	0.45	0.00	0.90	0.00	0.90	0.90	1.80	0.90	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	0.00	1.72	0.00	0.00	0.00	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	0.00	0.89	0.45	0.00	0.00	0.45	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	0.39	0.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	0.66	0.00	1.32	0.66	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	0.00	0.52	1.04	0.00	0.52	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	0.00	2.19	0.00	0.00	0.00	0.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	0.56	0.56	0.00	0.00	0.56	0.56	0.00	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	0.00	0.00	0.44	0.00	0.00	0.00	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	0.00	1.16	0.77	0.00	0.00	0.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	1.52	0.00	0.00	0.00	0.51	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	0.00	0.00	0.48	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	0.00	0.40	0.00	0.00	0.00	0.40	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	0.61	1.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	0.00	0.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	0.38	0.00	1.14	0.00	0.38	0.00	0.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	0.52	0.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	0.00	0.00	0.00	0.00	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	0.32	0.63	0.95	0.00	0.00	0.63	1.27	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	0.00	0.53	0.00	0.53	0.53	0.53	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	1.15	0.57	0.00	0.00	0.57	0.57	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	0.00	0.00	2.06	0.51	0.00	0.51	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	0.71	1.41	2.12	0.00	0.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	0.00	0.00	1.70	0.00	1.13	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	0.00	0.42	0.00	0.00	0.00	0.42	1.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	0.78	0.00	1.57	0.00	0.00	0.78	0.00	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	0.00	0.93	0.00	0.00	0.46	0.46	0.00	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	0.00	0.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	0.00	0.40	0.40	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	0.00	0.92	0.00	0.92	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	0.00	0.00	0.89	0.89	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	0.00	0.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	0.00	0.00	0.00	0.26	0.52	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	0.00	0.00	2.08	0.00	0.00	0.00	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	2.96	8.20	9.12	2.28	3.65	2.51	1.37	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	0.55	2.20	0.73	0.73	1.10	2.02	0.37	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	1.84	4.06	1.84	1.57	0.66	2.23	0.39	0.00	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	0.00	0.00	1.06	0.00	0.00	0.00	0.00	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	0.16	0.00	0.16	0.00	0.16	0.00	0.00	0.00	0.48
Mallassez-derived cells, donor3	11930-125I4	0.28	0.00	0.83	0.14	0.42	0.28	0.14	0.00	1.11
Mammary Epithelial Cell, donor1	11273-116H4	0.10	1.30	2.69	0.20	0.70	0.30	0.20	0.10	0.60
Mammary Epithelial Cell, donor2	11350-117G9	0.00	0.58	2.90	0.87	1.16	0.00	0.87	0.00	0.58
Mammary Epithelial Cell, donor3	11422-118F9	1.50	1.25	4.24	1.50	1.50	1.00	1.75	0.25	0.50
Mast cell - stimulated, donor1	11487-119E2	1.36	0.00	0.68	0.68	0.68	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	3.68	5.08	3.46	2.27	0.65	2.16	1.95	0.65	0.22
Mast cell, donor2	11565-120D8	0.00	0.89	1.19	0.30	0.00	0.00	0.00	0.00	0.00
Mast cell, donor3	11566-120D9	0.00	0.23	0.45	0.00	0.00	0.00	0.00	0.00	0.23
Mast cell, donor4	11567-120E1	0.18	0.18	0.53	0.18	0.00	0.53	0.18	0.00	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	5.54	4.21	2.33	1.55	1.44	5.54	3.44	0.22	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	0.00	1.17	0.58	0.00	0.00	0.58	1.17	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	2.41	2.87	1.03	0.92	0.46	1.15	0.46	0.23	0.34
Mast cell, expanded, donor8	11941-126A6	0.50	0.84	0.84	1.00	0.33	0.17	0.00	0.00	0.17
Melanocyte - dark, donor1	11502-119F8	4.28	9.95	4.38	3.68	1.99	3.08	2.89	0.60	0.20
Melanocyte - dark, donor2	11582-120F7	175.46	135.66	96.56	47.07	10.38	10.38	10.38	19.73	0.35
Melanocyte - dark, donor3	11663-122F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor1	11274-116H5	2.12	1.88	0.47	0.24	0.47	0.47	0.94	0.00	0.00
Melanocyte - light, donor2	11351-117H1	0.00	1.36	0.00	0.68	0.00	0.00	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	6.94	4.34	4.34	2.60	2.60	0.87	1.73	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	1.35	1.77	0.52	0.21	0.10	0.21	0.42	0.10	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	2.95	3.48	0.80	0.80	0.00	0.27	0.80	0.00	0.00
Meningeal Cells, donor1	11493-119E8	0.50	0.99	1.74	0.87	0.12	0.99	1.61	0.25	0.00
Meningeal Cells, donor2	11573-120E7	323.95	26.41	82.31	32.57	13.64	23.33	26.41	29.93	1.32
Meningeal Cells, donor3	11654-122E7	0.08	0.49	0.41	0.24	0.08	0.90	0.24	0.00	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	7.98	9.98	7.70	1.71	0.57	3.14	2.28	1.43	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	37.84	29.79	28.58	11.07	10.57	3.82	3.32	1.91	1.51
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	36.80	11.83	5.26	2.63	1.31	14.46	17.08	3.94	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	6.54	10.47	7.85	2.62	0.00	5.23	5.23	2.62	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	0.00	0.00	0.72	0.72	0.00	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	22.24	18.64	7.62	2.96	2.96	5.72	4.87	2.33	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	19.10	28.15	13.57	9.55	6.53	5.03	5.53	1.01	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	3.52	2.42	1.54	1.76	0.88	0.88	0.66	0.66	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	0.61	0.82	0.20	0.41	0.00	0.41	0.00	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	19.95	3.60	5.54	3.88	0.00	1.52	3.88	0.69	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	12.27	13.38	10.41	3.35	4.09	6.69	3.72	0.74	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	5.00	14.08	6.32	3.95	4.08	4.34	4.74	0.26	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	9.79	7.42	2.37	2.08	0.89	2.97	4.45	1.19	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	7.01	0.00	0.00	0.00	2.34	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	2.56	2.56	0.00	0.00	0.64	0.00	1.92	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	0.00	0.71	0.71	0.00	0.00	0.71	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	3.44	13.76	5.63	2.19	1.56	2.81	1.56	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	7.98	13.79	4.35	2.90	1.45	3.63	5.08	0.73	1.45
Mesothelial Cells, donor1	11247-116E5	73.45	84.33	54.63	15.91	12.46	2.65	1.59	5.04	0.53
Mesothelial Cells, donor2	12156-128G5	112.10	32.03	18.52	9.51	8.51	2.00	2.00	4.50	3.00
Mesothelial Cells, donor3	11402-118D7	57.96	66.92	36.20	12.50	8.96	3.54	2.53	5.28	1.01
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	6.75	33.76	1.35	2.70	4.05	27.01	6.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	6.65	20.93	12.81	7.14	4.19	12.81	3.45	0.49	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	5.30	4.12	2.94	2.06	1.18	2.06	1.77	0.29	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	3.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	2.79	9.61	10.85	3.72	3.10	6.51	3.10	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	3.32	4.36	4.56	2.70	1.87	2.49	1.87	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	2.32	0.00	0.00	0.00	0.00	0.00	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	3.50	13.51	10.26	5.76	4.50	6.26	1.75	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	2.33	0.47	3.26	3.26	0.47	1.40	1.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	19.47	0.00	0.00	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	4.88	12.19	8.54	6.30	1.63	5.89	3.05	0.41	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	1.58	1.98	2.38	3.56	1.98	1.19	1.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	8.55	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	4.42	16.81	15.04	8.85	4.42	3.54	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	2.66	6.08	5.32	5.32	0.76	1.90	2.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	2.63	0.00	1.32	3.95	2.63	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	2.97	12.73	12.10	6.15	3.18	5.52	3.40	0.64	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	0.92	0.92	0.00	0.92	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	1.79	8.64	6.56	5.07	0.89	3.87	2.68	0.00	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1.68	1.68	0.00	0.00	0.00	1.68	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	2.51	11.04	8.03	6.77	3.26	4.27	2.01	0.25	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	2.61	3.57	4.52	1.90	0.00	1.66	1.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.21	3.87	2.21	1.11	1.11	2.21	0.55	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	1.38	7.83	7.37	1.61	2.07	5.99	1.84	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	1.47	2.10	2.94	1.47	1.05	0.42	0.63	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	0.61	1.63	2.24	0.61	0.82	1.43	0.61	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	3.86	12.87	7.94	3.65	1.72	3.86	3.43	0.00	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	2.67	2.89	0.44	1.11	0.44	0.44	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	0.44	4.38	3.07	1.53	1.10	3.29	1.31	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	1.52	1.52	0.00	1.01	0.00	1.01	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	4.97	0.00	1.66	0.00	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	0.82	2.45	2.72	0.82	1.09	2.72	0.27	0.27	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	0.59	1.18	0.88	0.88	0.88	0.29	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	0.00	0.00	1.09	1.09	1.09	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.00	2.40	2.40	1.44	0.48	0.48	0.00	0.48	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	0.80	1.60	2.80	2.40	0.00	1.60	1.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	1.37	0.00	1.37	0.00	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	0.50	0.50	3.00	0.50	0.50	1.00	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	0.00	0.88	1.75	0.00	0.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	0.00	0.00	1.10	1.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	0.00	0.64	0.00	0.00	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	0.74	1.49	0.99	0.50	0.00	1.24	0.50	0.00	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	0.34	3.42	0.68	0.00	0.00	1.37	2.39	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	0.88	0.00	0.00	0.00	0.44	0.88	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	0.71	0.71	0.00	0.00	0.00	1.07	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	0.56	3.37	1.68	0.56	0.84	1.40	0.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	1.25	0.83	2.08	0.42	0.00	0.42	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	1.17	0.00	0.00	1.17	0.00	0.58	0.58	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	0.30	1.21	1.21	0.60	0.00	0.60	1.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	0.83	0.83	0.42	1.25	0.83	1.25	0.83	0.83	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	0.92	1.85	0.92	1.85	0.00	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	0.57	1.14	0.57	1.14	0.57	1.71	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	0.83	0.14	0.28	0.41	0.00	1.11	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	0.52	2.33	2.07	1.30	0.78	1.81	0.78	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	0.86	0.43	0.86	0.00	0.43	0.86	1.29	0.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.64	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	0.27	1.07	0.80	0.27	0.27	1.07	0.53	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	0.90	1.50	2.39	0.90	0.90	1.20	0.90	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	0.71	0.57	0.28	0.14	0.14	0.99	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	0.32	1.91	1.91	0.64	1.59	0.96	0.00	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	1.11	2.21	2.43	1.11	1.11	1.77	1.55	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	0.00	1.14	0.00	0.38	0.00	0.76	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	1.14	3.41	2.27	0.28	0.28	0.85	0.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	1.23	2.95	2.95	0.25	0.49	1.72	1.97	0.00	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	0.65	0.65	0.00	0.00	0.00	2.61	0.00	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	0.59	4.41	2.06	0.88	1.18	1.76	1.76	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	0.86	1.44	3.17	0.58	1.73	0.29	0.58	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	0.82	5.36	1.65	0.82	1.65	6.18	2.47	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	0.60	3.87	1.19	0.60	0.89	2.38	1.49	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	15.07	7.53	3.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	30.30	23.17	14.26	17.82	7.13	8.91	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	5.26	31.87	16.10	12.16	9.20	12.49	6.90	0.66	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	4.21	22.09	24.19	10.52	10.52	9.47	5.26	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	4.74	14.63	12.06	9.29	6.72	6.52	5.34	0.00	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	12.11	14.90	12.11	10.24	2.79	6.52	13.04	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	7.89	42.81	25.91	16.15	26.29	18.78	12.39	0.75	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	3.20	21.57	11.45	11.45	6.39	11.45	4.79	0.53	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	2.38	5.66	2.71	1.02	2.38	4.07	1.92	0.11	0.79
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	2.95	36.84	19.15	17.68	5.89	12.52	8.84	0.00	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	4.40	26.02	9.16	7.69	8.06	8.43	7.33	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	4.67	37.33	21.78	7.78	3.11	7.78	4.67	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	1.60	3.21	2.14	0.53	2.14	1.60	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	27.05	23.18	3.86	0.00	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	5.05	27.27	13.13	13.13	12.12	6.06	3.03	0.00	4.04
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	0.84	17.71	10.12	7.17	1.26	7.17	3.37	0.00	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	0.00	0.00	0.00	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	1.27	0.00	0.00	0.64	0.00	1.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	9.06	4.53	1.51	1.51	0.00	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	5.71	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	0.00	3.26	6.52	3.26	9.79	3.26	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	9.50	4.75	4.75	0.00	4.75	4.75	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	12.55	0.00	0.00	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	0.22	0.22	0.65	0.22	0.00	0.65	0.22	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	0.00	3.14	0.52	0.52	1.57	0.52	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	0.67	2.67	0.00	0.00	1.33	0.67	0.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	0.00	0.83	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	2.28	8.37	0.95	0.76	0.19	1.14	2.28	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	0.00	1.60	3.19	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	0.68	6.12	0.68	0.00	0.00	0.68	1.36	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	0.00	25.73	0.00	3.68	0.00	0.00	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	6.70	14.23	1.26	6.28	2.93	5.86	6.70	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	7.44	18.36	4.18	6.04	3.49	5.58	5.58	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	11.62	23.78	2.70	8.65	5.40	9.19	8.38	0.81	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	4.41	7.15	2.94	3.78	1.47	5.47	3.78	0.21	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	757.16	89.08	100.21	0.00	0.00	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	5.96	12.91	0.50	5.46	3.47	5.96	4.96	1.49	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	10.56	37.62	5.68	10.01	4.06	11.10	7.58	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	10.43	19.49	2.72	11.79	7.03	7.71	5.21	0.45	1.36
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	15.19	24.99	2.78	8.98	5.06	6.21	7.02	0.16	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	5.47	12.39	4.37	4.92	2.00	7.11	2.73	0.55	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	5.30	22.81	3.71	4.24	4.77	7.43	3.71	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	0.60	6.00	1.20	1.80	0.00	2.40	2.40	1.20	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	10.50	55.46	7.55	12.47	4.92	19.69	11.49	0.00	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	7.48	16.59	1.95	5.85	3.74	8.29	4.23	0.33	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	2.82	5.64	0.88	2.12	0.88	4.76	1.59	0.35	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.22	14.77	0.70	4.22	2.11	6.33	2.81	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	3.68	15.63	1.84	5.06	1.38	8.27	5.06	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	3.53	13.18	2.25	4.18	3.86	6.75	4.50	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	18.97	83.46	19.31	21.38	5.86	14.14	8.62	0.69	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	15.17	525.92	45.51	55.63	2.53	0.00	5.06	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	1.34	3.56	1.56	1.11	0.45	3.12	0.89	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	2.96	14.40	2.12	4.23	3.39	6.35	1.27	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	2.61	11.39	0.95	4.03	0.47	4.75	3.56	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	5.58	12.45	0.00	6.01	5.58	6.01	5.15	0.00	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	3096.52	135.42	794.44	0.00	27.08	18.06	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	3.67	13.00	1.33	2.33	3.33	7.33	0.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	0.45	1.80	0.00	0.90	0.00	1.35	0.90	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	0.79	11.11	0.40	2.38	1.59	3.17	3.17	0.00	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	2.79	6.50	0.93	0.93	0.00	3.71	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	3.78	20.05	2.27	9.08	3.78	11.73	4.16	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	5.21	16.29	0.98	5.54	2.61	4.24	3.58	0.65	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	7.41	17.43	2.61	5.23	3.05	4.36	3.05	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	2.71	2.26	0.45	1.36	0.00	3.62	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	0.88	8.82	4.41	2.65	3.53	5.29	1.76	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	1.33	5.98	0.66	1.33	0.66	3.32	4.65	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	7.44	23.81	3.97	5.95	3.97	7.94	3.47	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	8.80	23.35	3.83	5.36	3.06	7.27	5.36	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	16.94	39.62	9.07	13.91	7.56	18.45	7.86	0.91	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	7.07	9.06	2.43	3.98	1.99	6.41	4.64	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	2.71	21.68	2.71	6.10	4.74	5.42	6.10	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	235.04	10.22	45.99	0.00	10.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	7.93	28.05	6.71	9.15	7.93	12.80	5.49	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.33	28.64	6.61	9.13	4.41	14.48	5.04	0.31	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	12.11	36.32	3.33	8.78	1.51	6.96	6.66	1.21	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	3.16	30.85	3.16	3.96	6.33	7.12	7.12	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	18.14	92.96	19.27	10.20	5.67	5.67	9.07	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	192.20	15.17	25.29	10.12	0.00	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	0.62	0.75	0.87	0.12	0.25	0.62	0.00	0.12	0.00
Myoblast, donor2	11322-117D8	3.45	5.37	2.69	2.49	0.77	1.15	0.58	0.00	0.00
Myoblast, donor3	11398-118D3	1.18	1.35	0.50	0.50	0.67	1.18	0.17	0.17	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.15	0.88	1.31	0.88	0.58	0.73	0.29	0.15	0.00
Natural Killer Cells, donor1	11230-116C6	1.23	2.77	15.99	1.54	11.99	0.62	0.00	0.00	1.54
Natural Killer Cells, donor2	11311-117C6	0.30	5.73	21.11	3.92	18.39	0.90	0.60	0.00	4.22
Natural Killer Cells, donor3	11387-118C1	0.74	3.50	19.33	4.60	28.90	3.31	2.39	0.18	5.89
Neural stem cells, donor1	11275-116H6	0.00	0.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neural stem cells, donor2	11352-117H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	0.00	1.14	0.00	1.14	0.00	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	2.42	1.54	0.44	1.10	0.88	0.88	0.00	0.22	0.22
Neurons, donor3	11655-122E8	0.00	0.82	0.00	0.82	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	0.00	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.00	0.00	0.00	0.00	0.00	0.61	0.00	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	17.93	22.20	10.57	4.27	1.31	11.52	4.39	0.95	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	23.77	47.54	3.91	6.84	2.93	8.47	7.16	2.60	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	2.21	0.60	1.40	0.80	0.20	0.80	0.60	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	24.78	73.92	15.42	37.85	11.43	22.02	13.77	2.34	0.83
Olfactory epithelial cells, donor2	11934-125I8	1.88	11.72	2.03	4.05	2.17	4.49	2.03	0.00	0.00
Olfactory epithelial cells, donor3	11935-125I9	13.17	55.50	7.49	16.12	7.72	15.66	7.83	0.57	0.34
Olfactory epithelial cells, donor4	11936-126A1	6.82	17.04	4.77	4.97	1.75	10.62	4.68	0.29	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	23.47	16.85	13.84	7.82	10.23	3.01	6.62	4.21	3.01
Osteoblast - differentiated, donor1	11276-116H7	2.77	1.49	2.77	1.49	0.00	2.55	2.34	0.43	0.00
Osteoblast - differentiated, donor2	11353-117H3	0.00	4.57	9.14	3.43	0.00	0.00	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	7.45	4.34	4.97	1.24	0.62	1.24	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	5.08	4.69	5.08	2.54	1.37	2.74	4.10	0.59	0.20
Osteoblast, donor2	11354-117H4	0.00	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	1.07	1.60	0.71	0.00	0.00	0.18	0.18	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	0.84	1.10	0.76	0.51	0.08	0.34	0.25	0.00	0.00
Pericytes, donor1	11491-119E6	0.67	0.45	0.78	0.22	0.00	0.33	0.33	0.11	0.00
Pericytes, donor2	11571-120E5	0.45	0.45	1.13	0.00	0.00	0.91	0.45	0.00	0.00
Pericytes, donor3	11652-122E5	14.04	17.29	9.97	6.92	1.02	3.26	2.44	1.42	0.00
Perineurial Cells, donor1	11499-119F5	1.70	4.29	1.58	1.81	0.11	2.83	1.13	0.34	0.00
Perineurial Cells, donor2	11579-120F4	215.49	104.43	42.14	28.34	12.42	15.83	16.65	23.92	0.92
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	1.27	1.59	3.82	0.64	2.87	0.00	0.96	0.00	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	0.98	7.84	17.39	3.43	7.10	0.98	1.71	0.00	3.92
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	1.29	1.81	4.66	1.29	7.38	1.55	1.42	0.00	2.07
Placental Epithelial Cells, donor1	11278-116H9	0.24	0.24	0.72	0.48	0.00	0.00	0.00	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	0.00	0.00	2.22	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	2.75	1.57	1.57	0.20	0.59	0.79	0.39	0.39	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	1.27	9.18	3.48	1.58	3.16	3.16	1.58	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	6.38	9.19	8.82	5.25	1.69	3.38	1.13	0.75	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	2.22	7.57	3.79	3.00	1.57	3.13	0.39	0.65	0.13
Preadipocyte - breast, donor2	11328-117E5	3.83	6.08	12.38	3.60	1.13	1.35	0.45	1.13	0.00
Preadipocyte - omental, donor1	11468-119C1	37.08	26.11	28.02	17.16	12.25	8.95	5.65	1.39	0.96
Preadipocyte - omental, donor2	11329-117E6	20.95	22.26	22.26	8.29	8.73	8.29	5.24	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	2.29	7.02	3.15	1.86	3.58	3.01	0.86	0.14	0.29
Preadipocyte - perirenal, donor1	11469-119C2	25.59	5.91	27.56	3.94	7.87	5.91	5.91	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	13.82	4.30	7.37	1.23	1.23	3.99	4.61	2.15	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	1.77	6.02	3.19	2.12	0.00	1.06	0.89	0.35	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	12.09	14.30	9.88	3.92	2.72	4.09	2.21	0.68	0.85
Preadipocyte - visceral, donor1	11280-116I2	6.71	6.99	2.70	3.07	1.58	2.61	2.89	1.49	0.09
Preadipocyte - visceral, donor2	11357-117H7	5.52	10.58	5.52	5.52	0.92	1.84	2.30	1.84	0.92
Preadipocyte - visceral, donor3	11429-118G7	6.48	4.70	4.08	5.85	1.04	1.04	2.09	1.04	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	6.49	6.79	10.41	1.81	2.56	0.45	0.15	0.45	1.51
Prostate Epithelial Cells, donor2	11331-117E8	11.10	8.80	21.53	4.60	7.18	0.68	1.08	0.27	4.60
Prostate Epithelial Cells, donor3	11404-118D9	4.59	7.96	9.00	1.78	7.47	1.04	1.10	0.67	3.86
Prostate Stromal Cells, donor1	11254-116F3	72.21	50.91	40.89	15.60	17.77	8.66	6.83	7.06	2.39
Prostate Stromal Cells, donor2	11332-117E9	25.64	32.45	27.61	13.63	6.10	3.41	4.12	1.97	1.43
Prostate Stromal Cells, donor3	11405-118E1	104.59	88.74	57.87	18.87	23.04	15.33	8.13	9.59	8.13
Renal Cortical Epithelial Cells, donor1	11516-119H4	18.61	6.93	11.31	4.38	2.19	2.55	2.19	1.09	1.46
Renal Cortical Epithelial Cells, donor2	11596-120H3	11.23	8.04	5.27	2.98	1.66	1.11	1.25	0.83	0.83
Renal Epithelial Cells, donor1	11517-119H5	39.06	29.42	11.16	5.58	2.03	3.55	7.10	5.07	1.01
Renal Epithelial Cells, donor2	11597-120H4	17.78	30.59	19.21	14.23	4.98	5.69	4.98	3.56	4.27
Renal Epithelial Cells, donor3	11678-122H4	28.16	21.07	15.35	9.53	2.86	2.86	4.98	2.33	2.12
Renal Glomerular Endothelial Cells, donor1	11514-119H2	14.98	3.40	10.89	4.77	0.68	2.72	5.45	0.68	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	8.49	4.04	6.47	2.83	1.35	1.35	3.37	0.94	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	5.77	5.77	2.00	0.67	1.33	3.33	1.55	0.67	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.32	8.65	6.65	5.32	3.99	2.66	4.66	0.67	3.99
Renal Mesangial Cells, donor1	11518-119H6	123.69	63.83	29.27	19.59	7.26	7.48	15.63	12.10	3.96
Renal Mesangial Cells, donor2	11598-120H5	146.71	113.48	68.34	36.37	7.52	13.17	24.45	18.18	2.51
Renal Mesangial Cells, donor3	11679-122H5	112.07	76.01	52.43	28.30	6.10	4.72	6.10	14.15	1.94
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	11.81	13.15	5.64	1.34	2.95	1.34	2.15	1.34	1.34
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	10.96	15.18	8.86	4.22	4.22	1.27	3.37	0.42	5.90
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	32.98	30.08	21.60	10.41	3.09	2.31	4.05	5.01	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	106.05	92.82	45.12	22.04	5.44	4.67	3.63	30.85	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	305.28	130.75	75.89	43.21	11.09	12.79	9.95	52.87	3.41
Retinal Pigment Epithelial Cells, donor2	11608-120I6	159.51	102.91	66.89	33.96	8.23	8.23	11.32	41.16	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	73.01	55.20	20.83	17.81	8.28	4.77	6.27	7.78	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	16.84	31.14	29.93	9.49	25.79	4.54	2.81	2.00	9.35
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	5.36	4.47	1.79	0.89	0.89	3.57	4.47	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	7.71	8.26	6.60	5.50	4.95	8.81	16.51	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	3.48	1.74	1.74	0.58	1.74	2.90	2.32	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	17.68	8.84	6.11	5.72	1.56	7.41	11.83	1.69	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	6.55	14.80	5.76	7.85	1.99	3.18	4.37	1.19	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	10.37	10.71	5.47	5.91	2.57	3.35	4.02	0.78	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	12.03	8.43	16.25	8.31	2.98	6.20	8.56	2.60	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	9.79	19.35	9.56	8.62	1.98	3.03	5.59	1.17	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	6.93	15.02	9.25	6.24	3.24	4.62	6.70	0.92	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	15.88	6.02	9.86	5.61	2.74	5.34	13.28	2.74	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	8.93	14.52	8.17	4.84	1.66	4.84	6.05	1.21	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	6.45	8.24	4.30	2.33	1.97	1.97	3.40	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	14.06	8.18	16.78	6.60	1.72	6.46	14.20	3.16	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	8.05	17.71	10.41	6.87	1.93	6.65	5.58	1.29	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	9.29	20.36	11.28	8.19	2.21	4.87	4.65	1.99	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	12.04	4.21	5.54	2.29	0.76	3.25	13.00	1.53	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	8.66	14.53	6.61	5.22	2.42	5.22	5.59	1.21	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	10.15	13.15	2.82	2.82	1.88	6.58	6.20	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	9.02	3.32	5.57	2.39	1.73	6.10	7.96	2.65	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	9.05	14.50	5.55	5.35	2.92	7.69	5.94	1.17	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	6.11	15.28	6.87	7.64	2.10	4.01	5.16	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	7.16	3.20	6.09	3.31	0.75	5.13	7.48	1.60	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	7.85	14.58	8.97	9.81	1.40	4.77	6.73	1.40	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	7.18	7.52	5.13	5.30	1.03	1.88	2.22	0.51	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	6.38	3.65	4.38	1.64	1.64	2.01	6.38	1.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	8.71	16.43	10.55	7.11	2.21	4.41	5.64	0.98	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	9.00	10.07	6.85	4.03	1.48	3.63	3.09	1.75	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	6.84	3.30	8.02	2.12	0.71	2.36	11.09	0.94	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	10.12	20.24	8.13	9.92	2.58	6.55	6.35	1.39	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	7.72	11.69	5.38	4.91	2.34	4.91	3.51	1.40	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	5.60	2.28	5.39	1.87	1.24	1.45	4.35	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	11.28	14.82	5.97	5.53	0.88	3.98	6.19	0.88	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	4.80	6.68	3.76	3.34	1.67	2.09	2.09	0.00	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	4.31	2.69	3.63	2.29	1.21	2.15	4.04	1.21	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	5.11	8.00	3.92	2.04	1.19	3.24	4.77	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	4.43	6.36	2.70	3.66	0.77	2.70	4.05	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	3.44	3.09	4.47	2.75	0.52	0.69	5.50	1.72	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	3.84	6.45	2.47	1.65	0.69	2.74	2.88	0.55	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	3.78	9.52	3.78	4.10	1.81	1.81	2.96	0.66	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	10.40	5.45	9.03	3.75	2.22	4.60	9.37	2.05	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	12.13	16.13	8.14	7.10	2.52	6.95	6.21	1.63	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	8.80	9.06	5.86	4.53	1.87	6.66	4.53	2.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	18.94	6.08	11.48	6.78	0.97	5.25	17.15	3.73	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	12.14	18.57	8.10	9.29	3.57	2.86	6.19	1.19	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	10.88	12.09	5.44	5.84	1.41	7.05	10.08	1.81	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	4.61	2.83	4.90	3.30	0.85	2.07	6.22	1.04	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	5.24	10.13	7.69	3.84	2.45	2.10	7.69	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	5.74	4.53	4.84	3.63	1.21	0.91	3.02	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	2.69	2.81	4.41	1.47	0.49	0.98	2.08	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	5.97	4.80	2.91	4.08	2.91	1.46	3.06	0.29	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	3.04	6.69	7.91	1.83	1.83	2.43	2.43	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	2.11	1.21	3.01	2.11	0.00	1.81	3.62	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	4.30	10.86	9.73	7.01	3.39	3.17	1.58	0.23	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	0.60	4.49	3.89	4.19	1.20	0.60	1.50	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	13.34	7.79	11.22	6.73	4.25	4.01	6.38	1.53	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	3.20	5.12	9.39	2.35	3.42	2.35	3.42	0.43	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	0.60	2.40	1.80	1.80	0.00	0.60	0.60	0.00	0.00
Schwann Cells, donor1	11498-119F4	107.76	40.25	49.84	23.70	3.95	14.67	19.94	12.22	0.38
Schwann Cells, donor2	11578-120F3	6.80	17.01	6.80	0.00	3.40	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	1.31	2.85	1.97	0.66	0.66	1.53	0.88	0.00	0.00
Sebocyte, donor1	11220-116B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.10
Sebocyte, donor2	11301-117B5	0.00	0.00	0.46	0.46	0.00	0.00	0.00	0.00	0.46
Sebocyte, donor3	11378-118B1	0.62	2.06	2.06	0.41	0.62	0.21	0.00	0.41	0.00
Sertoli Cells, donor1	11255-116F4	11.60	34.79	101.05	31.48	51.35	6.63	3.31	0.00	6.63
Sertoli Cells, donor2	11333-117F1	25.42	50.84	53.66	50.84	22.59	19.77	11.30	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	13.37	22.26	9.85	7.21	3.08	5.72	5.54	1.50	0.26
Skeletal Muscle Cells, donor2	11358-117H8	9.40	5.06	13.01	1.45	2.89	4.34	2.17	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	10.87	5.85	9.20	1.67	0.00	3.34	2.51	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	5.50	4.08	7.23	3.46	0.47	2.51	1.89	1.26	0.00
Skeletal Muscle Cells, donor5	11455-119A6	3.72	3.72	5.95	3.42	1.19	2.23	1.93	0.59	0.15
Skeletal Muscle Cells, donor6	11459-119B1	3.39	1.69	4.46	1.69	0.00	2.00	1.39	0.77	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	31.88	21.67	12.10	7.81	2.90	6.68	7.18	3.28	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	11.42	16.27	9.85	6.99	0.43	4.00	2.57	1.85	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	5.65	8.14	5.36	2.28	1.59	3.97	2.58	1.19	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	39.77	50.55	31.26	18.11	20.14	11.96	6.99	3.03	1.01
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.07	5.79	8.69	2.90	0.00	1.45	1.45	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	5.50	3.30	6.33	3.03	0.69	2.06	2.20	0.69	0.41
Skin - palm, donor1	10286-104F7	34.92	8.06	8.06	2.69	2.69	5.37	10.74	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	0.43	1.01	2.02	0.29	1.01	0.00	0.00	0.00	4.04
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	2.45	2.45	4.09	0.00	0.82	0.00	0.00	0.00	4.91
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	0.78	1.17	1.56	0.00	0.78	0.13	0.13	0.26	3.64
Small Airway Epithelial Cells, donor1	11256-116F5	0.56	1.25	3.48	0.97	0.83	0.56	0.14	0.14	3.20
Small Airway Epithelial Cells, donor2	11334-117F2	0.42	1.97	3.09	0.00	0.14	0.14	0.14	0.14	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	1.27	1.06	4.44	0.00	1.69	0.42	0.42	0.21	4.02
Small Airway Epithelial Cells, donor3	11406-118E2	1.35	1.87	3.60	0.52	1.27	0.67	0.22	0.30	2.32
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	20.68	5.25	7.71	1.85	0.93	0.00	1.23	2.47	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	21.34	9.34	22.46	8.89	12.23	4.00	6.67	1.56	2.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	51.73	27.63	15.28	7.64	6.47	15.28	8.23	2.35	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	24.31	30.72	16.57	15.91	29.39	9.06	9.06	0.88	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	28.75	17.33	20.08	9.45	10.63	4.33	5.51	0.79	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	55.62	23.18	17.00	11.59	10.04	11.59	24.72	7.73	3.86
Smooth Muscle Cells - Bladder, donor1	11519-119H7	122.09	186.14	41.03	34.03	4.00	17.01	11.01	13.01	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	44.58	31.94	26.08	12.11	8.65	8.12	6.39	3.19	1.20
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	2.88	8.42	3.32	2.66	1.55	1.11	0.66	0.44	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	68.50	12.42	28.29	10.63	7.30	7.81	5.76	6.40	1.92
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	2.93	3.58	2.93	1.30	0.98	1.63	0.65	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	20.08	18.90	8.56	7.09	2.66	4.13	5.02	0.89	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	11.67	7.40	2.85	1.99	1.00	2.28	0.43	0.43	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2.28	1.95	0.81	0.49	0.65	0.81	0.33	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	1.83	0.91	0.91	0.91	0.30	0.91	2.44	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	49.00	29.55	19.19	12.88	8.33	15.91	9.85	4.80	1.26
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	6.12	6.12	6.12	6.12	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	39.58	27.18	46.73	17.17	7.63	8.58	5.25	6.68	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	7.37	7.67	3.69	1.77	0.74	1.33	1.18	0.44	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	7.75	9.69	6.24	4.09	1.51	2.58	1.08	0.86	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	6.61	8.61	3.36	1.78	1.57	2.10	1.68	0.73	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	22.27	23.67	24.59	13.77	9.44	6.81	7.27	1.86	1.70
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	24.79	14.01	22.64	11.86	6.47	2.16	1.08	5.39	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	27.49	12.55	37.36	10.76	8.37	4.78	3.89	1.49	1.79
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	11.61	7.85	6.49	3.76	2.05	9.90	4.78	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	1.10	3.93	1.18	1.18	0.55	3.14	1.18	0.31	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	3.42	4.63	1.81	2.92	0.60	0.60	1.11	0.30	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	51.20	61.44	74.41	46.65	17.07	6.37	4.78	4.78	2.73
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	55.55	21.13	38.04	17.51	9.66	7.85	7.25	1.81	3.62
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	14.31	15.63	7.42	3.71	2.12	2.65	6.09	1.32	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	78.70	32.89	38.08	23.04	7.59	13.18	9.99	6.92	1.33
Smooth Muscle Cells - Prostate, donor2	11335-117F3	68.50	54.85	40.70	24.42	11.90	6.39	4.63	4.76	2.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	2.03	2.28	2.03	0.51	0.76	0.76	0.76	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	35.43	22.92	15.08	7.99	6.63	4.67	5.28	1.96	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	41.26	31.51	38.26	27.76	5.25	5.25	0.75	2.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	0.00	5.17	2.58	2.58	27.14	0.00	3.88	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	233.93	60.92	49.76	28.83	19.07	14.88	19.53	10.23	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	50.49	79.77	39.38	35.34	9.09	5.55	3.53	4.04	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	22.88	21.31	31.34	12.22	5.95	6.58	3.13	0.94	1.57
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.95	1.77	3.54	0.29	0.00	2.36	1.47	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	0.17	0.50	0.17	0.25	0.00	0.17	0.17	0.08	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	6.54	10.28	6.07	1.87	0.00	4.67	2.80	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	43.75	22.31	16.84	13.67	4.89	7.34	7.05	3.02	1.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	12.75	12.49	12.24	4.33	5.10	5.61	4.59	0.76	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	28.77	14.48	27.45	12.97	2.44	7.90	7.15	2.26	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	11.04	11.04	3.63	2.24	1.40	3.77	1.82	1.82	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	2.85	6.03	2.51	1.01	0.92	1.84	0.92	0.75	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	0.48	0.48	0.00	0.00	0.48	0.48	0.00	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	41.59	16.88	22.26	8.81	2.69	4.65	4.65	3.43	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	15.25	11.27	8.84	7.95	4.20	3.76	3.54	2.21	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	16.68	20.48	9.66	3.80	4.68	3.80	3.22	3.22	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	14.97	25.46	5.44	7.00	2.33	20.02	11.86	0.97	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	4.76	8.99	3.17	3.70	2.12	4.23	1.85	0.00	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	23.06	27.52	7.07	4.09	4.84	10.04	8.93	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	21.20	12.22	10.78	2.52	3.95	8.26	5.03	1.44	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	0.00	0.85	0.28	0.28	0.28	0.00	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	1.18	0.39	0.00	0.39	0.39	0.00	1.18	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	105.14	73.14	21.84	16.00	8.13	16.51	14.73	2.79	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	64.69	59.90	20.76	14.38	2.80	21.96	16.37	2.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	30.93	76.49	22.57	15.47	8.78	17.56	10.03	1.25	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	13.75	31.63	11.92	5.96	3.21	10.08	12.38	0.92	0.00
Synoviocyte, donor1	11291-117A4	2.36	3.53	1.68	1.18	0.67	0.50	0.17	0.00	0.00
Synoviocyte, donor2	11368-117I9	18.61	57.50	15.76	8.55	4.36	9.39	4.02	1.17	1.01
Synoviocyte, donor3	11440-118H9	29.71	24.58	22.56	16.31	4.92	6.48	5.14	2.46	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	0.71	1.07	0.00	0.00	0.00	0.71	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	5.95	0.00	0.00	0.00	3.96	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	3.24	3.01	0.46	1.16	0.23	0.46	0.69	1.16	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	0.00	0.14	3.37	0.29	0.14	0.07	0.00	0.00	0.86
Tracheal Epithelial Cells, donor2	11369-118A1	1.93	1.55	5.80	0.39	3.09	1.55	0.39	0.39	2.32
Tracheal Epithelial Cells, donor3	11441-118I1	0.00	0.00	4.01	0.00	0.00	0.00	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	25.34	28.66	33.59	9.47	24.11	4.92	2.46	1.97	7.38
Urethra, donor2	10319-105A4	55.75	14.39	30.57	8.99	5.40	7.19	3.60	8.99	8.99
Urothelial Cells, donor1	11520-119H8	0.27	0.53	1.59	0.00	0.27	0.27	0.00	0.00	1.06
Urothelial Cells, donor2	11600-120H7	0.00	0.40	4.81	0.40	0.00	0.00	0.00	0.00	1.20
Urothelial Cells, donor3	11681-122H7	0.23	0.46	5.50	0.46	0.00	0.46	0.00	0.00	2.06
Urothelial cells, donor0	11216-116B1	0.22	0.22	2.01	0.00	0.22	0.22	0.00	0.00	1.34
Whole blood (ribopure), donor090309, donation1	12179-129A1	0.00	0.89	8.01	0.89	1.78	0.00	0.00	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	2.86	0.00	8.58	0.00	2.86	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	0.00	0.00	7.53	1.37	1.37	0.68	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	0.00	2.07	5.17	2.41	2.41	1.03	0.69	0.00	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	0.58	2.91	3.49	1.16	4.65	1.74	0.58	0.00	2.32
Whole blood (ribopure), donor090612, donation1	12182-129A4	0.00	0.00	12.49	2.08	6.25	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	0.00	0.00	9.18	0.00	3.67	0.00	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	0.00	2.74	5.48	0.00	1.83	0.00	0.00	0.00	2.74
Wilms' tumor cell line:G-401	10809-111A8	0.99	1.73	1.48	0.86	0.25	0.00	0.25	0.49	0.12
Wilms' tumor cell line:HFWT	10597-108E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	67.87	132.68	45.25	33.52	12.01	15.08	23.46	11.45	5.31
achilles tendon, donor2	10292-104G4	2.07	8.27	12.40	0.00	0.00	6.20	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	1.09	1.63	0.27	0.54	0.00	0.27	1.36	0.27	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	0.42	0.85	0.63	0.00	0.85	1.06	0.00	0.00	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	0.82	2.99	2.45	0.54	1.09	2.18	0.82	0.27	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	1.32	11.02	6.61	3.53	2.20	6.17	0.00	0.44	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	0.00	0.78	0.00	0.00	0.00	0.39	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	0.70	0.93	0.93	0.46	0.00	0.46	0.23	0.23	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	0.00	0.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	0.00	0.93	0.00	0.93	0.00	0.00	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.41	1.65	2.47	1.65	0.00	1.23	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	0.00	1.23	0.31	0.00	0.31	0.92	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	0.00	2.99	0.00	0.85	0.00	4.27	0.43	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	0.30	1.82	0.30	0.00	0.00	1.21	0.00	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	0.00	1.20	0.72	0.00	0.00	0.72	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	0.22	0.22	0.22	0.22	0.00	0.45	0.00	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	3.72	0.00	0.00	0.00	1.86	1.86	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	2.64	7.16	8.29	1.51	1.88	3.39	3.01	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	3.05	1.31	1.31	1.74	0.44	2.18	0.87	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	35.61	54.36	1.87	7.50	7.50	18.74	7.50	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	0.71	1.88	4.71	2.59	14.84	0.94	1.41	0.24	2.12
adipose tissue, adult, pool1	10010-101C1	65.77	40.49	17.68	16.60	6.36	6.98	8.07	4.50	0.62
adipose, donor1	10184-103D4	0.00	4.10	3.52	1.17	0.00	0.00	1.17	0.00	0.00
adipose, donor2	10185-103D5	1.22	15.41	6.49	5.27	5.68	2.03	2.43	0.41	0.41
adipose, donor3	10186-103D6	2.45	12.80	4.90	5.72	120.62	45.20	83.59	0.27	0.82
adipose, donor4	10187-103D7	5.20	38.14	12.13	18.20	253.09	131.75	198.49	1.73	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	0.00	0.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	0.00	14.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	6.43	18.94	12.15	7.50	3.93	8.93	3.22	1.43	1.07
amniotic membrane cells, donor1	12235-129G3	2.32	6.03	5.56	1.85	6.03	0.46	2.55	0.46	0.23
amniotic membrane cells, donor2	12236-129G4	0.68	0.68	0.68	0.34	1.35	1.69	2.03	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	1.47	0.29	2.65	0.88	1.18	0.00	0.00	0.29	0.00
amygdala - adult, donor10196	10167-103B5	4.74	11.86	1.19	8.30	0.00	7.11	7.11	1.19	1.19
amygdala, adult, donor10252	10151-102I7	4.46	14.19	5.07	2.84	1.01	7.10	4.46	0.81	0.20
amygdala, newborn, donor10223	10360-105E9	17.11	12.91	3.55	3.55	4.20	2.90	3.23	0.65	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	68.12	50.55	59.85	25.85	6.37	6.62	3.69	6.88	1.02
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	0.33	1.67	0.33	0.00	0.00	0.00	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	28.05	44.33	11.77	9.61	12.55	19.61	6.86	2.16	0.98
appendix, adult	10189-103D9	17.85	20.96	7.37	2.72	3.10	3.88	2.33	0.78	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	1.72	7.57	3.10	2.06	0.34	2.75	3.44	1.03	0.00
artery, adult	10190-103E1	16.30	33.97	10.87	10.87	2.72	0.00	1.36	2.72	1.36
astrocytoma cell line:TM-31	10425-106D2	21.59	24.34	13.47	6.66	10.43	5.65	5.22	1.74	0.43
b cell line:RPMI1788	10427-106D4	0.00	0.00	0.00	0.00	0.15	0.00	0.00	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	3.61	2.22	3.61	2.77	0.83	1.39	1.11	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	4.17	5.16	8.93	2.08	5.36	2.38	1.19	0.50	2.38
bile duct carcinoma cell line:TFK-1	10496-107C1	9.37	33.48	26.11	8.37	21.76	16.40	5.36	0.84	9.04
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	0.00	0.00	0.56	0.00	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	35.85	38.24	16.95	10.54	6.95	10.97	6.63	3.69	2.28
blood, adult, pool1	10053-101G8	0.00	8.86	2.21	0.00	6.64	4.43	0.00	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	0.00	0.00	0.00	0.00	0.00	1.71	0.00	0.00	0.00
bone marrow, adult	10192-103E3	56.01	41.84	13.50	18.22	11.47	2.70	4.72	3.37	1.35
brain, adult, donor1	10084-102B3	4.10	11.28	5.13	4.10	6.15	3.08	0.00	1.03	2.05
brain, adult, pool1	10012-101C3	3.23	8.69	4.01	2.56	2.34	3.67	1.78	0.67	0.11
brain, fetal, pool1	10085-102B4	0.00	16.03	5.34	2.67	0.00	5.34	5.34	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	0.33	0.66	0.99	0.66	0.99	0.99	0.00	0.66	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	1.25	1.37	0.87	0.25	0.62	0.62	0.25	0.00	0.25
breast, adult, donor1	10080-102A8	60.61	43.56	10.73	13.26	13.89	12.63	10.73	3.16	2.53
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	49.67	71.90	49.54	14.48	12.58	17.53	9.15	10.29	22.99
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	16.70	40.51	15.46	9.59	3.09	8.66	10.82	4.33	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	4.12	5.08	2.91	2.66	3.63	0.48	0.97	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	6.58	19.28	7.99	6.58	0.94	4.23	8.46	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	11.59	4.59	2.73	0.88	1.64	1.42	1.64	1.42	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	0.95	9.82	2.54	4.12	1.27	1.58	1.27	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	0.80	0.80	1.33	1.86	0.00	0.80	1.86	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	9.21	8.06	4.61	2.30	1.15	2.30	1.15	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	7.03	7.03	5.02	4.02	2.34	6.69	1.51	0.67	0.17
caudate nucleus, adult, donor10258	10379-105H1	6.11	3.82	3.82	4.58	2.29	5.35	6.88	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	8.42	12.82	3.66	4.76	8.06	4.03	5.49	0.00	1.10
cerebellum - adult, donor10196	10173-103C2	0.00	2.91	2.91	0.00	2.91	2.91	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	1.92	4.70	1.49	0.43	0.64	1.28	0.64	0.00	0.00
cerebellum, adult, pool1	10083-102B2	1.03	3.45	0.34	2.76	1.38	1.38	0.69	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	9.96	8.30	2.49	1.66	3.32	1.66	3.32	0.00	0.00
cerebral meninges, adult	10188-103D8	9.33	15.63	5.04	3.78	1.76	3.28	1.26	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	9.50	9.50	2.92	2.19	1.46	3.65	2.92	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	0.14	3.45	4.03	2.73	3.31	2.30	1.73	0.00	1.44
cervical cancer cell line:ME-180	10553-107I4	6.13	12.10	10.77	2.98	9.11	7.46	7.29	1.82	4.97
cervix, adult, pool1	10013-101C4	39.58	45.15	19.00	9.55	6.82	10.29	6.19	4.62	1.78
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	2.79	14.35	9.89	2.79	10.87	7.94	1.95	0.14	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	0.00	2.61	0.00	2.61	0.00	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	3.36	1.99	1.24	0.87	0.75	0.75	1.12	0.87	0.00
choriocarcinoma cell line:SCH	10785-110H2	5.91	11.09	4.56	2.96	1.97	0.74	1.60	1.85	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	0.24	0.95	0.71	0.00	0.00	0.24	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	14.53	14.82	11.40	3.42	1.99	1.14	1.71	2.28	1.14
chorionic membrane cells, donor2	12239-129G7	5.77	5.97	4.28	1.29	2.59	0.89	0.80	0.80	0.20
chorionic membrane cells, donor3	12240-129G8	15.94	4.40	23.08	3.85	2.75	0.55	1.10	2.20	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	1.01	2.02	0.00	1.01	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	0.38	0.19	0.38	0.19	0.00	0.38	0.19	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	7.39	10.56	1.69	2.75	3.59	7.39	4.22	0.42	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	12.07	21.06	9.76	6.68	2.05	8.22	12.84	3.60	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	14.51	24.19	9.68	7.26	2.90	9.19	12.58	2.90	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	13.03	14.05	5.29	4.07	2.24	10.79	13.23	2.85	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	0.59	2.06	0.29	0.59	0.29	0.59	0.29	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	25.28	37.53	9.64	8.34	6.52	20.85	10.69	1.04	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	3.66	5.94	11.66	5.49	5.49	0.69	0.91	0.91	2.51
clear cell carcinoma cell line:TEN	10636-108I6	29.32	18.91	7.63	6.25	10.06	9.37	6.07	2.78	3.30
colon carcinoma cell line:CACO-2	10513-107D9	9.15	12.63	8.79	4.03	4.58	2.93	2.56	1.46	1.28
colon carcinoma cell line:COLO-320	10420-106C6	79.44	46.75	19.76	12.92	0.00	8.36	13.68	14.06	0.38
colon, adult, donor1	10082-102B1	5.95	19.04	11.90	5.95	9.52	2.38	1.19	0.00	2.38
colon, adult, pool1	10014-101C5	26.09	30.08	22.44	8.81	17.04	7.64	3.53	3.06	1.29
colon, fetal, donor1	10070-101I7	10.51	35.23	29.05	12.98	18.54	21.63	9.89	0.62	6.80
common myeloid progenitor CMP, donor1	12130-128D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	3.82	4.25	4.67	2.12	0.85	0.42	0.42	0.85	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	1.81	4.83	3.47	1.66	0.30	2.41	1.21	0.15	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	2.82	3.24	3.53	1.97	0.00	2.54	1.41	1.27	0.99
corpus callosum, adult, pool1	10042-101F6	9.29	9.29	4.98	2.87	2.99	1.77	1.55	0.66	0.33
cruciate ligament, donor2	10295-104G7	37.28	27.56	13.78	6.48	2.43	12.97	6.48	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	26.48	21.67	4.82	4.82	2.41	19.26	3.21	3.21	0.00
diencephalon, adult	10193-103E4	2.88	6.96	2.64	3.12	1.92	2.16	1.20	0.24	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	49.75	30.52	15.13	7.44	7.95	8.72	11.80	4.62	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	0.48	2.41	2.17	0.48	2.17	0.96	0.24	0.00	0.24
ductus deferens, adult	10196-103E7	47.84	24.42	7.48	8.97	2.99	2.99	1.99	3.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	8.64	36.01	12.96	8.64	14.40	11.52	5.76	1.44	8.64
duodenum, fetal, donor1, tech_rep2	10071-101I8	11.77	13.24	16.92	10.30	14.71	5.15	2.94	0.74	5.89
dura mater, adult, donor1	10041-101F5	47.24	25.44	13.87	5.95	4.62	5.29	3.06	3.47	0.83
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	0.22	1.11	4.44	0.89	0.67	0.00	0.89	0.00	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	3.87	7.16	8.45	3.01	4.87	2.29	4.87	0.14	1.86
embryonic pancreas cell line:1B2C6	10604-108F1	8.02	9.25	1.85	3.08	0.62	3.08	4.32	0.62	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	18.47	22.70	17.86	7.87	6.66	5.15	3.33	4.54	1.82
embryonic pancreas cell line:1C3IKEI	10606-108F3	8.95	5.87	3.40	2.47	1.85	3.09	1.85	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	9.19	11.82	3.94	2.63	1.31	6.57	1.31	1.31	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	43.24	42.23	23.80	11.40	7.37	6.70	3.02	2.68	2.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	0.54	1.45	0.00	1.09	0.18	1.09	0.36	0.18	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	13.83	17.21	16.56	4.82	12.22	10.13	5.95	1.45	2.09
epidermoid carcinoma cell line:A431	10426-106D3	25.90	24.34	15.23	6.00	5.56	9.89	10.34	2.89	5.45
epidermoid carcinoma cell line:Ca Ski	10431-106D8	5.94	12.32	12.43	3.41	3.63	4.62	5.06	0.33	0.55
epididymis, adult	10197-103E8	50.44	30.14	13.61	16.33	5.44	5.02	4.60	3.14	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	1.24	5.14	1.77	1.24	0.00	4.26	1.42	0.18	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	0.39	0.00	1.97	0.00	0.00	0.39	0.00	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	0.26	1.57	1.83	0.66	0.79	0.66	0.52	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	0.39	3.54	3.35	1.28	0.59	2.56	1.38	0.30	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	0.11	1.46	1.34	0.90	0.90	1.68	0.45	0.22	0.00
esophagus, adult, pool1	10015-101C6	26.44	27.61	19.22	7.54	10.62	6.26	4.88	4.14	5.95
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	2.13	2.13	1.38	0.88	1.13	2.00	0.50	0.00	1.00
eye - muscle inferior rectus, donor1	10272-104E2	24.15	33.80	2.41	4.83	2.41	14.49	19.32	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	25.25	4.21	6.31	0.00	2.10	0.00	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	23.81	17.86	4.46	1.49	0.00	11.91	5.95	1.49	0.00
eye - muscle superior, donor2	10297-104G9	32.10	26.37	9.17	5.73	2.29	8.03	4.59	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	4.37	4.37	0.00	0.00	2.91	1.46	2.91	0.00	1.46
eye, fetal, donor1	10054-101G9	48.81	52.88	15.76	11.19	9.41	22.63	8.39	10.17	1.27
fibrosarcoma cell line:HT-1080	10758-110E2	0.00	3.59	1.15	1.15	0.13	0.00	0.00	0.00	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	3.09	12.58	10.21	4.75	3.80	4.99	2.37	0.00	0.95
frontal lobe, adult, pool1	10040-101F4	2.35	3.19	1.60	1.60	0.47	1.69	1.60	0.19	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	9.31	22.52	8.71	5.70	10.81	11.71	7.51	1.50	2.70
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	9.24	8.41	5.30	2.83	11.16	5.03	2.47	1.10	5.85
gall bladder, adult	10198-103E9	19.31	13.52	15.21	4.83	8.45	3.86	2.90	0.48	3.62
gamma delta positive T cells, donor1	11937-126A2	0.54	2.68	16.11	5.37	25.23	1.07	1.07	0.00	1.07
gamma delta positive T cells, donor2	11938-126A3	1.87	2.99	21.66	8.96	21.29	4.11	1.49	0.75	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	17.32	14.57	18.16	8.45	10.77	8.87	5.70	1.48	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	3.67	3.87	6.96	1.55	6.19	1.74	1.55	1.35	2.71
gastric cancer cell line:AZ521	10549-107H9	1.31	1.80	0.98	0.16	0.33	0.33	0.66	0.16	0.00
gastric cancer cell line:GSS	10560-108A2	0.00	0.92	1.83	1.83	0.92	3.66	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	44.09	18.28	15.99	8.91	5.94	8.22	8.00	5.48	2.06
giant cell carcinoma cell line:LU65	10487-107B1	0.00	1.61	0.80	0.46	0.69	1.03	0.46	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	21.13	22.53	5.04	2.80	0.84	2.10	1.54	2.24	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	9.73	16.21	9.23	4.24	6.48	3.24	2.24	1.50	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	0.88	3.31	1.21	0.77	0.99	1.77	0.66	0.11	0.11
glioma cell line:GI-1	10413-106B8	11.42	14.94	7.91	2.93	8.20	9.66	7.32	1.17	0.59
globus pallidus - adult, donor10196	10175-103C4	3.64	4.37	1.46	3.64	1.46	4.37	2.19	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	3.91	9.76	5.37	1.71	1.46	3.17	1.22	1.22	0.00
globus pallidus, adult, donor10258	10367-105F7	10.95	26.01	1.37	5.48	2.74	5.48	5.48	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	4.80	9.06	1.07	1.60	0.53	1.60	1.07	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	0.00	7.34	2.45	0.00	0.00	2.45	4.89	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	5.23	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	2.24	5.76	2.56	2.24	1.92	2.88	0.96	0.96	0.96
hIPS +CCl2, biol_rep1	14383-156B9	17.45	25.25	4.13	3.67	1.84	11.02	22.50	0.92	0.46
hIPS +CCl2, biol_rep2	14384-156C1	17.38	13.26	5.03	1.83	0.46	7.77	21.95	2.29	2.29
hIPS +CCl2, biol_rep3	14385-156C2	21.90	22.54	7.09	1.93	0.00	10.95	23.19	1.93	1.93
hIPS, biol_rep1	14380-156B6	15.81	12.94	2.87	0.00	0.00	7.19	18.68	1.44	1.44
hIPS, biol_rep2	14381-156B7	26.06	26.75	7.54	2.06	1.37	6.86	13.03	2.06	1.37
hIPS, biol_rep3	14382-156B8	9.93	6.62	2.21	5.52	1.10	3.31	6.62	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	9.27	8.67	3.89	5.08	1.20	1.79	1.20	0.90	0.30
heart - pulmonic valve, adult	10206-103F8	18.83	15.95	5.49	9.41	1.83	3.66	1.31	1.57	0.52
heart - tricuspid valve, adult	10207-103F9	9.16	31.64	16.65	12.49	2.50	9.16	0.83	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	4.29	17.14	6.33	4.69	6.12	7.35	4.49	1.43	0.82
heart, adult, diseased, donor1	10051-101G6	6.39	19.16	5.96	6.39	3.41	12.77	4.68	0.85	2.13
heart, adult, pool1	10016-101C7	10.35	20.47	11.96	5.98	3.91	8.28	2.76	1.61	0.92
heart, fetal, pool1	10046-101G1	15.09	17.15	8.32	4.93	5.54	13.96	3.18	1.54	0.92
hepatic mesenchymal tumor cell line:LI90	10778-110G4	6.79	17.89	6.79	5.24	6.17	11.72	3.70	0.00	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	11.89	22.59	11.89	1.19	2.38	2.38	4.76	1.19	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	8.51	13.26	9.17	4.75	5.41	3.87	3.09	1.77	2.21
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	7.65	10.07	10.92	2.79	4.98	2.06	2.55	1.82	1.46
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	11.01	11.01	11.72	5.66	5.86	3.33	2.73	2.32	1.11
hepatoma cell line:Li-7	10484-107A7	9.90	18.13	17.79	4.78	8.67	11.12	6.56	0.44	1.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	0.95	17.98	0.00	2.84	1.89	2.84	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	9.18	13.88	7.76	5.51	3.47	9.80	3.47	0.20	0.20
hippocampus, adult, donor10258	10374-105G5	1.99	5.98	2.99	1.00	0.00	3.98	6.47	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	3.17	6.70	1.41	3.17	1.06	3.52	1.06	0.35	1.76
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	3.66	20.14	6.71	6.71	0.00	7.32	6.10	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	2.95	7.66	4.12	2.95	0.98	2.36	2.55	0.79	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	4.32	7.87	5.33	3.05	0.00	3.81	5.08	1.02	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	3.95	4.51	1.13	1.13	0.56	1.13	0.56	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	1.03	4.65	2.58	4.65	0.77	1.29	1.03	1.03	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	3.04	2.66	1.14	2.28	0.00	1.14	1.90	0.38	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	1.75	0.58	0.88	0.88	0.00	0.58	0.58	0.29	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	1.51	3.02	2.37	2.80	0.43	0.22	0.22	0.43	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	2.09	0.42	2.50	0.42	0.00	0.00	0.42	0.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	0.95	1.89	2.37	0.47	0.24	0.00	0.71	0.00	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	5.46	5.46	3.54	2.89	0.32	0.64	1.29	0.00	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	5.39	1.35	4.71	0.00	0.67	0.67	2.02	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	2.35	12.05	5.32	4.23	0.47	4.23	4.07	0.78	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	3.93	16.70	7.37	4.91	0.00	6.88	4.91	0.49	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	2.62	15.71	5.24	4.36	0.87	5.24	9.60	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	0.38	2.29	0.95	0.95	0.19	0.19	0.38	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	0.00	1.74	0.44	0.00	0.00	0.44	0.44	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	2.00	4.00	0.00	1.00	0.50	0.50	1.00	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	1.32	3.58	0.94	2.83	0.57	0.75	0.57	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	2.27	3.64	1.36	2.73	1.36	0.91	1.36	0.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	1.88	3.13	2.51	1.88	0.94	1.25	0.63	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	1.96	3.92	1.96	1.80	0.16	0.65	0.82	0.16	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	1.74	3.48	0.29	1.45	0.00	0.58	0.29	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	1.49	4.48	0.90	2.69	0.30	0.90	0.90	0.60	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	5.17	24.94	9.24	7.39	1.48	7.57	5.73	0.55	1.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	5.14	27.67	8.56	6.28	1.71	8.56	6.85	1.43	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	14.29	43.69	13.07	6.53	0.41	13.07	11.43	1.22	2.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	1.41	1.06	0.35	1.76	0.00	0.70	0.35	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	0.95	3.17	3.17	1.27	0.95	0.00	0.00	0.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	2.72	6.05	1.51	0.61	0.30	0.00	2.42	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	3.10	3.62	2.07	1.55	1.03	0.00	1.03	1.55	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	2.66	3.98	1.33	1.33	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	4.62	2.05	1.54	0.51	0.26	0.51	0.77	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	6.65	9.20	3.07	0.77	1.02	0.26	2.30	0.26	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	2.27	3.03	2.27	0.76	0.00	1.51	0.76	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	4.03	6.72	2.69	2.69	0.00	1.34	1.68	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	9.18	35.74	12.80	9.90	0.97	12.32	11.59	2.17	3.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	18.27	40.11	11.59	8.91	1.34	12.48	15.15	2.23	2.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	8.78	53.17	10.24	8.78	1.95	13.17	16.10	1.46	4.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	1.22	3.36	1.22	1.53	0.31	0.61	0.92	0.61	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	9.76	42.29	6.51	0.00	0.00	0.00	3.25	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	2.65	9.60	2.98	1.32	0.00	2.32	1.99	0.99	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	1.09	4.38	2.19	1.64	0.55	0.00	0.00	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	3.26	5.79	1.45	2.17	0.72	0.36	1.09	0.00	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	1.78	7.12	1.07	0.36	1.42	1.07	0.36	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	0.00	1.19	1.19	0.00	1.19	2.39	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	2.03	3.52	0.41	0.41	0.00	1.08	0.41	0.27	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	0.54	4.58	0.27	0.54	0.00	0.00	0.00	0.00	0.27
immature langerhans cells, donor1	11904-125F5	2.18	4.12	13.08	1.45	8.48	0.48	1.21	0.24	10.17
immature langerhans cells, donor2	11905-125F6	0.00	2.38	18.22	0.79	7.92	0.00	0.00	0.00	4.75
insula, adult, pool1	10039-101F3	2.93	4.16	1.04	1.14	0.57	1.80	1.99	0.19	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	5.20	19.18	17.56	3.58	15.93	5.20	3.90	1.30	21.46
kidney, adult, pool1	10017-101C8	18.12	20.33	14.52	7.81	6.11	5.11	2.50	1.30	1.60
kidney, fetal, pool1	10045-101F9	69.53	31.48	16.13	7.92	10.12	10.12	9.05	10.33	2.05
large cell lung carcinoma cell line:IA-LM	10509-107D5	3.55	3.83	2.70	1.42	2.41	1.99	1.42	0.14	1.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	2.63	5.67	1.94	0.83	0.55	1.66	1.38	0.41	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	0.18	1.10	1.65	1.10	1.10	0.92	0.55	0.00	0.00
left atrium, adult, donor1	10079-102A7	24.52	28.33	5.99	10.90	1.09	16.89	8.17	2.18	2.18
left ventricle, adult, donor1	10078-102A6	7.08	12.14	5.56	6.07	5.06	5.06	2.53	0.00	1.01
leiomyoblastoma cell line:G-402	10721-110A1	1.37	1.92	0.55	0.27	0.00	3.28	0.82	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	51.37	40.95	38.08	15.09	7.18	2.16	1.80	2.87	2.87
leiomyoma cell line:15242A	10570-108B3	26.63	24.46	28.80	13.59	5.43	0.00	1.09	2.17	1.09
leiomyoma cell line:15425	10571-108B4	12.38	10.93	7.53	5.83	0.97	0.97	0.97	1.94	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	19.05	6.35	0.00	0.00	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	8.36	10.46	7.32	3.14	5.23	4.18	2.09	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	14.40	21.60	14.88	4.96	14.40	15.11	12.28	1.89	0.47
liposarcoma cell line:KMLS-1	10782-110G8	0.16	1.25	0.47	0.47	0.00	1.09	0.16	0.16	0.16
liposarcoma cell line:SW 872	10726-110A6	0.00	1.46	0.49	0.24	0.00	0.00	0.24	0.00	0.00
liver, adult, pool1	10018-101C9	35.33	43.27	41.33	10.21	43.59	11.83	10.05	3.73	6.97
liver, fetal, pool1	10086-102B5	4.70	20.70	19.75	6.58	21.64	8.47	7.53	0.94	8.47
locus coeruleus - adult, donor10196	10182-103D2	2.04	3.35	0.44	0.58	0.00	0.87	0.58	0.29	0.15
locus coeruleus, adult, donor10252	10165-103B3	6.27	7.94	4.80	2.95	2.77	3.69	1.48	0.37	0.55
locus coeruleus, adult, donor10258	10375-105G6	3.67	16.93	3.39	5.92	2.54	5.08	3.67	0.00	1.97
locus coeruleus, newborn, donor10223	10362-105F2	15.98	10.09	7.15	2.10	2.10	1.26	0.84	0.84	0.84
lung adenocarcinoma cell line:A549	10499-107C4	10.93	18.27	12.87	4.01	9.13	13.98	9.83	2.21	1.80
lung adenocarcinoma cell line:PC-14	10408-106B3	31.02	28.96	4.14	5.52	6.20	8.96	5.52	2.76	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	65.91	21.35	7.25	4.35	4.22	5.54	5.54	8.30	1.19
lung, adult, pool1	10019-101D1	16.30	16.30	13.35	4.37	9.45	6.26	3.19	1.54	3.43
lung, fetal, donor1	10068-101I5	79.91	23.69	26.83	10.56	8.28	15.70	11.42	3.71	5.99
lung, right lower lobe, adult, donor1	10075-102A3	7.79	22.45	7.33	7.79	12.37	9.16	2.29	2.75	6.87
lymph node, adult, donor1	10077-102A5	3.31	8.99	3.31	5.21	4.73	4.73	3.31	0.47	1.42
lymphangiectasia cell line:DS-1	10727-110A7	0.00	0.00	0.00	0.00	0.22	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	11.89	33.98	20.39	3.40	17.84	17.84	13.59	3.40	4.25
mature adipocyte, donor1	12231-129F8	182.04	63.49	18.65	11.54	13.32	31.52	26.20	8.44	1.33
mature adipocyte, donor2	12232-129F9	117.67	42.13	20.55	9.96	14.11	22.21	14.32	6.64	0.62
mature adipocyte, donor3	12233-129G1	57.84	35.80	21.10	12.09	16.59	12.09	12.80	1.90	1.66
mature adipocyte, donor4	12234-129G2	102.13	45.80	17.90	8.95	17.90	27.11	26.58	9.48	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	5.72	8.34	1.43	1.43	3.57	2.86	4.77	1.43	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	0.00	5.64	1.13	1.13	0.00	2.26	4.51	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	3.49	6.80	3.31	2.76	2.02	4.23	2.02	0.18	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	5.72	9.53	2.22	1.59	1.27	4.77	3.49	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	5.54	10.24	3.41	3.41	2.13	1.71	1.71	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	2.03	8.44	1.35	2.87	0.51	2.36	2.53	0.17	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	4.46	7.22	4.46	2.12	1.70	3.82	1.91	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	1.93	9.63	0.00	0.00	1.93	1.93	17.34	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	401.90	71.77	100.48	0.00	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	4.67	7.18	1.79	1.44	2.87	0.72	1.79	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	38.94	31.15	9.09	3.89	5.84	11.68	8.44	2.60	0.65
medulla oblongata, adult, donor10252	10155-103A2	15.64	13.16	6.35	4.18	6.35	6.81	2.48	2.17	0.46
medulla oblongata, adult, pool1	10038-101F2	10.12	5.80	4.41	2.04	2.29	3.02	1.39	1.31	0.16
medulla oblongata, newborn, donor10223	10361-105F1	20.83	28.47	6.25	7.99	3.82	4.17	4.51	0.69	1.04
medulloblastoma cell line:D283 Med	10838-111E1	4.21	1.55	1.55	0.66	0.89	0.44	0.66	1.11	0.00
medulloblastoma cell line:ONS-76	10759-110E3	2.69	4.77	4.77	0.98	1.71	5.14	1.71	1.10	2.81
melanoma cell line:COLO 679	10514-107E1	0.00	1.29	0.86	0.00	0.00	0.00	0.00	0.00	0.00
melanoma cell line:G-361	10465-106H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	31.30	48.66	42.69	17.91	12.84	4.16	3.08	4.52	2.53
merkel cell carcinoma cell line:MKL-1	10843-111E6	8.81	16.74	14.98	6.17	1.76	5.29	5.29	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	66.88	35.51	26.70	14.26	3.89	3.37	4.93	12.96	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	5.98	5.83	6.29	1.99	1.53	1.23	1.38	0.92	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	1.64	0.55	1.82	1.82	0.91	1.27	0.73	0.18	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	8.70	1.24	5.80	4.97	1.66	1.66	1.24	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	0.56	0.14	0.56	0.14	0.00	0.14	0.14	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	1.35	1.16	1.54	1.16	0.19	0.58	0.58	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	8.33	11.11	11.11	4.16	0.69	2.08	2.08	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	0.34	0.34	1.54	0.69	0.17	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	0.58	1.04	0.58	0.81	0.35	0.35	0.23	0.12	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	5.44	2.92	5.44	1.86	1.33	0.40	1.46	0.53	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	1.22	0.54	1.76	0.95	0.14	0.54	0.68	0.27	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	12.09	3.84	8.25	3.13	1.14	1.56	1.85	1.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	1.65	5.27	2.63	1.98	0.33	1.32	0.99	0.33	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	26.71	8.58	17.02	4.98	4.15	3.60	4.84	2.35	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	3.49	18.50	8.38	3.49	1.05	3.49	2.44	1.40	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	1.63	1.02	2.45	0.82	0.61	0.41	0.41	0.61	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	5.39	12.22	10.06	3.24	1.80	1.80	2.16	0.36	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	39.83	13.97	30.21	11.07	5.17	3.93	4.24	4.86	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	40.58	33.29	29.87	10.94	8.21	2.74	4.10	1.60	1.60
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	29.79	4.62	18.46	3.36	2.94	0.84	0.42	5.03	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	1.20	2.24	2.09	0.60	0.75	0.60	0.45	0.60	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	23.63	7.62	17.42	6.48	5.60	2.28	2.80	3.94	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	5.89	6.26	2.95	2.58	1.47	2.21	1.47	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	36.91	37.77	30.62	15.74	6.30	4.58	3.43	2.86	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	0.84	2.53	1.68	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	12.33	14.61	10.50	3.65	5.48	7.76	6.85	0.46	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	15.35	22.25	15.60	7.16	5.37	4.86	3.58	1.53	1.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	12.83	14.66	12.56	7.07	4.45	4.19	2.36	1.05	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	8.63	17.56	15.71	5.85	4.93	4.62	4.31	1.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	14.12	18.59	11.77	7.30	4.24	3.06	3.29	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	15.23	14.89	12.52	4.06	3.05	2.71	3.38	1.35	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	14.15	15.72	11.79	6.29	4.72	3.93	1.57	0.79	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	11.58	16.68	10.19	8.34	5.56	0.46	5.56	0.46	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	48.30	0.00	0.00	0.00	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	16.15	14.42	10.96	6.35	6.06	4.61	5.19	2.02	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	11.60	14.06	12.05	5.13	3.57	3.35	2.68	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	13.70	11.54	9.37	6.49	6.25	2.88	3.12	0.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	17.60	16.87	3.67	3.67	2.93	2.20	3.67	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	14.77	13.43	9.06	6.71	5.37	2.01	3.02	0.00	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	11.05	15.56	10.64	6.14	4.91	1.64	3.28	1.23	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	16.75	15.46	7.30	4.73	3.87	3.87	1.72	1.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	19.14	16.41	13.67	5.47	2.73	5.47	5.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	20.66	15.49	5.16	0.00	5.16	15.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	13.64	13.97	13.64	6.82	6.50	6.50	5.85	1.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	8.73	11.64	16.00	1.45	2.91	4.36	2.91	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	15.99	31.45	17.06	10.13	8.53	12.79	9.06	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	7.36	14.72	15.54	10.63	3.27	7.36	1.64	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	12.44	19.44	15.94	7.39	5.44	6.61	3.50	0.78	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	29.38	16.79	14.69	4.20	8.39	10.49	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	12.92	14.90	8.94	8.94	3.97	4.97	9.93	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	19.07	4.77	0.00	0.00	0.00	4.77	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	7.12	21.35	18.97	5.34	4.15	8.89	5.34	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	8.53	14.62	12.18	7.31	2.44	6.09	4.87	1.22	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	7.60	15.20	12.67	7.60	2.53	3.80	5.70	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	24.14	25.52	19.31	11.38	3.79	7.59	9.66	2.41	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	32.24	27.94	25.79	12.90	10.75	4.30	6.45	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	31.93	15.97	27.94	3.99	7.98	3.99	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	44.77	55.10	24.11	6.89	10.33	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	25.26	43.19	17.52	8.15	4.89	7.33	7.74	3.67	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	32.57	45.28	23.04	8.74	2.38	7.15	11.92	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	16.51	30.07	11.20	11.79	2.36	5.90	4.13	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	18.08	26.18	17.46	8.73	1.25	4.99	5.92	0.94	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	17.38	50.79	20.05	8.02	2.67	5.35	5.35	4.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	10.64	17.74	4.73	3.55	0.00	2.37	2.37	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2.57	15.41	5.14	5.14	0.00	2.57	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	10.33	8.95	5.51	2.75	0.69	1.38	2.07	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	27.21	51.46	17.32	11.38	1.98	7.92	8.91	3.46	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	25.79	47.10	16.82	16.82	1.12	10.09	5.61	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	37.53	51.52	20.99	12.09	0.64	6.36	7.63	1.91	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	47.95	73.34	31.03	26.19	5.64	13.70	10.48	3.22	1.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	69.78	117.75	41.43	45.79	8.72	15.26	17.44	2.18	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	36.74	64.62	24.07	20.27	10.14	15.20	12.67	1.27	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	7.28	12.74	7.28	3.03	2.43	9.71	5.46	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	40.67	13.56	18.08	9.04	9.04	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	7.41	39.54	12.36	9.06	1.65	11.53	3.29	5.77	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	14.88	14.88	4.76	3.97	2.58	4.17	3.57	1.59	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	13.63	20.77	18.17	6.81	2.27	6.49	4.22	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	17.32	23.43	14.26	7.13	0.00	7.13	5.09	2.04	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	0.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	4.25	12.05	3.31	1.89	0.24	5.67	8.74	0.47	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	19.92	35.91	11.35	9.04	4.40	15.06	9.04	1.62	2.55
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	4.27	4.27	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	11.10	3.08	0.31	1.44	1.54	2.88	2.57	0.41	0.10
mesothelioma cell line:Mero-25	10850-111F4	1.59	2.50	1.59	1.36	2.27	0.68	0.68	0.00	0.91
mesothelioma cell line:Mero-41	10851-111F5	4.89	2.93	5.38	1.22	1.47	0.00	0.00	0.00	0.49
mesothelioma cell line:Mero-48a	10852-111F6	37.42	30.78	20.81	14.17	9.08	6.20	5.98	4.65	1.77
mesothelioma cell line:Mero-82	10853-111F7	13.14	19.97	13.14	4.47	7.36	8.67	7.10	1.05	1.31
mesothelioma cell line:Mero-83	10854-111F8	50.22	33.87	17.19	12.94	8.17	6.30	7.32	5.11	1.19
mesothelioma cell line:Mero-84	10855-111F9	5.81	5.31	4.04	1.26	2.53	1.26	0.76	0.51	0.25
mesothelioma cell line:Mero-95	10856-111G1	234.37	142.45	71.02	45.96	32.71	17.18	14.91	22.57	3.31
mesothelioma cell line:NCI-H2052	10847-111F1	18.22	14.08	8.12	5.80	2.82	2.82	3.31	1.66	1.33
mesothelioma cell line:NCI-H226	10846-111E9	39.64	44.16	38.19	15.57	16.29	6.15	7.42	2.71	4.16
mesothelioma cell line:NCI-H2452	10848-111F2	28.53	21.87	22.38	18.11	15.20	7.86	9.22	1.88	0.85
mesothelioma cell line:NCI-H28	10845-111E8	12.21	20.10	9.67	3.31	4.07	2.80	3.05	0.76	0.76
mesothelioma cell line:No36	10857-111G2	2.61	2.94	2.28	1.63	0.33	0.98	2.61	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	1.35	1.90	2.98	0.54	0.27	1.08	1.90	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	0.00	0.00	1.15	0.00	0.00	0.00	0.19	0.00	1.73
migratory langerhans cells, donor2	11902-125F3	0.00	0.00	0.12	0.00	0.00	0.00	0.00	0.00	0.12
migratory langerhans cells, donor3	11903-125F4	0.00	0.00	0.36	0.00	0.18	0.00	0.00	0.00	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	1.31	6.86	10.77	4.90	1.31	1.31	0.65	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	11.23	49.38	13.14	9.54	7.21	12.50	8.05	2.54	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	7.83	8.29	8.06	1.61	5.30	3.92	2.99	1.84	0.92
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	0.00	1.90	2.66	0.19	0.19	0.38	0.00	0.00	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	0.00	3.88	1.66	0.37	0.74	2.77	0.55	0.18	0.55
myeloma cell line:PCM6	10474-106I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	0.51	2.03	0.51	0.00	0.00	1.01	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	8.43	17.26	14.51	5.88	7.65	4.90	3.73	1.96	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	0.22	0.33	1.45	0.22	0.45	0.11	0.00	0.00	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	0.00	0.37	1.99	0.15	0.15	0.00	0.07	0.00	0.96
nasal epithelial cells, donor2	12227-129F4	0.00	1.66	1.10	0.55	1.10	4.97	5.52	0.55	1.10
neuroblastoma cell line:CHP-134	10508-107D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	8.22	6.75	4.01	1.69	0.63	2.11	1.05	1.48	0.21
neuroblastoma cell line:NH-12	10555-107I6	0.00	0.37	0.19	0.00	0.19	0.00	0.37	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	10.68	16.84	4.74	8.54	2.61	8.78	5.46	1.19	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	47.04	61.77	13.46	16.95	15.36	19.64	14.57	6.02	0.95
neuroectodermal tumor cell line:TASK1	10774-110F9	16.10	18.11	8.05	4.23	5.23	2.62	3.22	1.61	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	5.72	3.18	1.27	0.00	0.64	4.45	2.54	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	5.86	21.83	9.32	5.06	3.99	9.05	4.26	0.53	0.53
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	0.00	2.40	1.60	0.00	1.60	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	0.64	5.13	3.21	1.92	0.32	2.89	0.96	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	4.99	3.68	4.20	2.36	0.79	0.79	0.79	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	4.03	5.16	1.78	1.31	0.75	1.41	1.50	0.28	0.09
occipital cortex - adult, donor10196	10172-103C1	4.12	6.18	2.06	6.18	2.06	2.06	6.18	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	5.37	14.76	8.59	3.22	2.95	6.17	2.95	0.54	0.54
occipital cortex, newborn, donor10223	10355-105E4	6.19	4.00	0.73	2.91	4.00	2.55	0.73	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	2.36	8.66	3.15	2.89	1.05	4.99	4.72	0.00	1.05
occipital lobe, fetal, donor1	10073-102A1	8.15	2.57	0.00	1.72	0.86	3.00	1.29	0.43	0.00
occipital pole, adult, pool1	10036-101E9	2.05	4.18	1.73	1.50	0.87	1.42	1.02	0.39	0.39
olfactory region, adult	10195-103E6	3.44	9.55	2.29	1.91	1.34	4.39	3.44	0.57	0.38
optic nerve, donor1	10277-104E7	10.01	6.00	10.01	4.00	0.00	0.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	91.47	66.29	58.43	22.78	26.65	7.52	10.48	8.32	2.51
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	52.89	40.53	22.26	12.78	4.81	12.64	23.22	7.01	4.81
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	24.04	21.00	17.27	5.76	16.76	5.42	3.89	1.69	5.08
oral squamous cell carcinoma cell line:SAS	10544-107H4	52.90	34.77	33.15	17.67	12.13	10.40	13.40	11.78	1.62
osteoclastoma cell line:Hs 706.T	10704-109H2	0.00	0.00	0.00	0.29	0.00	0.29	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	27.10	40.18	13.08	2.80	5.61	47.65	32.70	1.87	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	1.91	2.97	1.27	0.64	0.42	1.06	1.48	0.00	0.00
ovary, adult, pool1	10020-101D2	21.93	20.79	8.56	5.15	4.89	7.42	6.11	3.41	1.05
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	0.55	4.03	2.20	0.55	0.73	0.73	0.55	0.00	0.18
pancreas, adult, donor1	10049-101G4	5.64	9.41	33.86	2.82	16.93	4.70	0.00	0.00	18.81
pancreatic carcinoma cell line:NOR-P1	10698-109G5	1.68	5.31	4.47	3.63	0.56	1.12	1.96	0.56	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	9.88	10.05	10.22	4.43	6.81	5.11	4.94	0.34	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	76.33	36.26	16.23	8.28	10.43	8.78	8.61	8.11	5.13
paracentral gyrus, adult, pool1	10035-101E8	2.01	3.39	2.11	1.46	0.92	1.56	1.10	0.18	0.18
parietal cortex, adult, donor10258	10373-105G4	8.07	6.61	0.73	0.00	0.73	7.34	4.40	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	3.76	2.82	0.94	1.88	0.00	0.94	1.88	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	1.71	5.99	3.71	4.28	2.00	3.99	1.71	0.57	0.57
parietal lobe, adult, pool1	10034-101E7	2.64	3.52	2.47	0.79	0.53	0.62	0.62	0.26	0.09
parietal lobe, fetal, donor1	10072-101I9	5.82	5.82	0.00	3.88	3.88	6.79	8.73	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	4.86	7.10	2.99	2.62	3.36	3.74	2.62	0.00	0.75
parotid gland, adult	10199-103F1	6.78	14.80	24.67	8.63	9.25	1.85	2.47	1.23	0.62
penis, adult	10200-103F2	21.48	26.86	13.96	10.74	4.30	4.30	3.76	1.07	2.69
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	0.00	0.19	0.19	0.37	0.37	0.19	0.37	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	119.76	192.90	98.34	27.68	34.82	31.03	25.06	10.93	12.38
pineal gland - adult, donor10196	10179-103C8	7.74	5.81	1.94	1.94	1.29	1.94	2.58	1.94	0.00
pineal gland, adult, donor10252	10160-103A7	7.11	3.55	2.37	1.18	0.59	6.51	3.55	0.59	0.59
pineal gland, adult, donor10258	10377-105G8	6.90	4.39	2.51	0.63	0.63	1.25	1.88	1.25	1.25
pituitary gland - adult, donor10196	10180-103C9	11.13	11.13	3.04	0.00	0.00	2.02	3.04	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	14.59	16.16	4.17	3.65	1.56	7.82	3.65	4.17	0.52
pituitary gland, adult, donor10258	10378-105G9	43.41	8.51	2.55	6.81	0.85	3.40	4.26	0.00	2.55
placenta, adult, pool1	10021-101D3	26.02	17.95	12.47	4.62	6.45	6.24	2.80	2.69	1.51
plasma cell leukemia cell line:ARH-77	10840-111E3	0.00	0.00	0.13	0.00	0.13	0.13	0.00	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	0.78	0.78	0.78	0.16	0.16	0.47	0.00	0.16	0.00
pons, adult, pool1	10033-101E6	4.30	1.81	1.46	0.52	0.77	0.60	1.03	0.09	0.34
postcentral gyrus, adult, pool1	10032-101E5	1.92	4.62	2.70	1.57	0.52	1.83	1.05	0.17	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	9.91	19.37	4.81	3.93	1.31	9.32	7.28	1.46	0.58
prostate cancer cell line:PC-3	10439-106E7	26.14	25.05	10.16	10.53	6.53	16.88	10.35	5.08	1.63
prostate, adult, pool1	10022-101D4	37.91	27.39	19.59	7.62	8.07	7.16	4.90	3.45	4.35
putamen, adult, donor10196	10176-103C5	1.89	6.85	3.30	1.89	1.65	2.83	1.42	0.00	0.47
putamen, adult, donor10252	10152-102I8	3.92	3.92	0.00	0.00	1.96	0.00	0.00	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	10.93	8.74	1.09	1.09	0.00	7.65	16.39	1.09	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	5.32	6.04	1.69	3.14	1.69	3.87	3.14	0.48	0.97
putamen, newborn, donor10223	10365-105F5	3.75	9.75	3.75	3.00	3.00	8.25	4.50	0.00	1.50
rectal cancer cell line:TT1TKB	10469-106I1	2.62	4.07	1.45	0.58	1.75	3.20	0.87	1.16	0.58
rectum, fetal, donor1	10067-101I4	29.21	57.03	20.86	11.13	9.74	40.34	16.69	4.17	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	3.82	5.51	4.45	1.27	1.48	1.91	1.06	0.42	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	21.54	51.36	50.12	14.08	19.05	10.77	9.53	5.80	16.15
retina, adult, pool1	10030-101E3	147.01	55.56	21.67	15.41	5.77	11.73	5.86	30.02	0.10
retinoblastoma cell line:Y79	10475-106I7	0.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	3.32	4.92	0.98	0.37	0.74	1.84	0.61	0.74	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	6.19	7.87	1.69	2.25	0.84	5.91	3.37	0.84	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	134.90	68.21	21.98	13.64	5.30	25.77	9.85	12.88	0.76
salivary acinar cells, donor1	11771-123I7	0.16	0.16	0.65	0.00	0.00	0.16	0.16	0.00	0.00
salivary acinar cells, donor2	11772-123I8	0.69	0.28	0.55	0.00	0.69	0.69	0.41	0.00	0.00
salivary acinar cells, donor3	11773-123I9	0.00	0.66	1.99	0.66	0.66	0.66	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	18.87	13.73	24.59	5.15	9.15	1.14	3.43	1.14	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	16.19	19.22	8.94	5.65	4.89	2.95	3.12	0.93	0.76
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	12.81	20.92	7.05	9.05	6.23	6.82	5.05	1.41	1.29
seminal vesicle, adult	10201-103F3	38.09	38.09	10.05	10.58	1.59	4.23	3.17	2.65	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	41.05	23.32	18.46	8.50	18.46	3.40	2.67	2.19	1.94
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	0.00	0.25	0.25	0.00	0.25	0.25	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	0.00	3.01	4.01	0.00	1.00	0.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	2.55	1.61	1.88	0.81	0.13	0.13	0.13	0.00	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	0.33	0.55	1.11	0.22	1.22	0.00	0.22	0.00	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	1.68	3.23	6.45	1.29	6.97	1.29	0.77	0.39	2.97
skeletal muscle - soleus muscle, donor1	10282-104F3	9.22	7.80	3.55	4.26	4.26	9.93	2.13	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	10.43	14.99	8.28	5.04	6.84	9.83	2.28	1.56	1.32
skeletal muscle, fetal, donor1	10066-101I3	16.08	35.18	4.02	10.05	4.02	43.22	10.05	1.01	0.00
skin, adult, donor1	10074-102A2	6.79	54.28	0.00	27.14	27.14	6.79	0.00	6.79	6.79
skin, fetal, donor1	10065-101I2	13.89	30.30	15.15	6.94	6.31	14.52	4.42	2.52	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	38.02	30.68	13.67	7.00	6.00	8.67	9.67	8.00	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	1.89	2.84	0.95	0.95	0.63	1.26	2.52	0.32	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	0.19	0.19	0.00	0.19	0.00	0.39	0.00	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	45.66	34.45	15.66	10.88	8.08	11.37	14.50	5.27	1.32
small cell lung carcinoma cell line:NCI-H82	10842-111E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	3.92	7.19	3.70	1.09	1.31	1.74	2.83	0.44	0.00
small intestine, adult, pool1	10024-101D6	8.12	22.93	37.03	10.51	38.82	5.97	2.15	0.48	1.79
small intestine, fetal, donor1	10064-101I1	9.34	23.10	4.42	13.51	12.53	15.23	5.65	1.72	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	18.46	13.34	18.98	6.67	12.31	2.56	6.15	1.03	0.00
smooth muscle, adult, pool1	10048-101G3	11.11	12.41	8.01	3.88	3.36	10.60	5.69	3.10	1.03
somatostatinoma cell line:QGP-1	10781-110G7	1.61	1.61	0.80	0.54	0.80	1.34	0.27	0.00	0.54
spinal cord - adult, donor10196	10181-103D1	9.18	12.85	1.84	2.98	2.75	7.11	3.90	0.69	0.69
spinal cord, adult, donor10252	10159-103A6	16.56	15.38	7.89	4.73	7.10	11.04	3.94	1.18	0.79
spinal cord, adult, donor10258	10369-105F9	23.52	20.06	6.23	2.77	2.77	4.84	5.53	2.08	2.08
spinal cord, fetal, donor1	10056-101H2	67.69	75.01	18.30	12.81	7.93	37.20	21.95	5.49	2.44
spinal cord, newborn, donor10223	10359-105E8	45.46	26.18	10.10	6.89	5.51	7.35	6.89	3.67	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	9.41	13.14	5.53	2.69	3.88	6.57	3.88	1.19	0.15
spleen, adult, pool1	10025-101D7	2.09	5.62	3.41	1.87	2.31	3.96	0.88	0.22	0.55
spleen, fetal, pool1	10044-101F8	6.12	3.50	3.81	1.75	1.99	3.02	1.75	0.79	1.03
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	0.00	0.00	0.31	0.00	0.00	0.00	0.00	0.00	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	84.30	114.50	43.67	29.81	22.97	39.87	24.11	7.60	9.68
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	8.04	14.68	5.59	4.89	5.59	2.10	1.05	2.45	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	4.30	12.51	10.16	2.35	5.47	4.30	3.91	1.17	4.30
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	6.42	9.00	12.38	4.16	13.96	5.97	2.14	0.00	2.59
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	5.08	1.27	5.08	1.27	0.85	0.85	0.42	0.00	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	1.69	0.85	0.42	0.00	0.00	1.69	0.85	0.00	0.00
stomach, fetal, donor1	10062-101H8	9.61	34.18	8.54	2.14	2.14	7.48	5.34	0.00	2.14
submaxillary gland, adult	10202-103F4	10.82	11.39	18.23	3.99	6.84	1.71	2.28	0.57	1.14
substantia nigra - adult, donor10196	10178-103C7	0.00	379.92	162.82	0.00	0.00	108.55	108.55	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	7.48	11.01	6.65	4.57	2.49	2.70	1.66	0.21	0.42
substantia nigra, adult, donor10258	10371-105G2	2.59	6.72	3.10	0.00	1.03	2.59	3.62	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	16.25	24.02	4.24	6.36	4.95	9.19	5.65	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	7.34	9.63	7.11	5.04	4.36	11.00	2.52	0.92	0.46
temporal lobe, adult, pool1	10031-101E4	3.81	5.59	2.80	1.78	1.27	3.14	1.70	0.17	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	2.85	10.68	0.00	0.71	2.85	9.26	4.99	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	4.83	3.96	4.40	1.76	0.00	4.40	3.96	0.44	0.00
tenocyte, donor1	11763-123H8	5.59	19.90	5.93	2.44	5.59	4.89	2.09	0.35	0.00
tenocyte, donor2	11765-123I1	19.84	44.25	24.42	13.35	5.34	9.54	6.87	1.53	0.00
tenocyte, donor3	11768-123I4	8.15	28.54	13.34	4.82	4.45	6.67	4.45	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	3.40	12.58	3.91	1.19	1.87	2.55	6.80	1.36	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	1.08	2.00	1.08	0.77	1.54	0.31	0.46	0.15	0.15
teratocarcinoma cell line:PA-1	10807-111A6	0.46	2.79	0.93	0.15	0.00	0.62	0.62	0.46	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	3.05	8.76	5.97	1.40	3.17	1.52	2.16	0.76	0.76
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	1.13	1.13	1.51	1.51	0.38	1.51	0.38	0.38	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	1.20	0.33	3.93	0.44	2.18	0.00	0.11	0.33	1.20
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	0.65	2.61	1.95	1.30	2.61	2.28	0.33	0.00	0.33
testis, adult, pool1	10026-101D8	20.62	20.94	7.84	6.12	1.83	5.69	2.25	1.29	0.54
testis, adult, pool2	10096-102C6	4.96	2.26	4.06	3.16	0.45	4.96	2.71	0.90	0.00
thalamus - adult, donor10196	10168-103B6	3.31	7.73	2.21	2.21	1.10	2.21	2.21	0.00	0.00
thalamus, adult, donor10252	10154-103A1	6.72	9.22	6.41	3.44	2.81	3.59	1.72	0.78	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	13.86	6.16	3.08	0.00	3.08	1.54	7.70	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	4.61	9.88	1.81	4.78	2.31	4.45	2.31	0.66	1.48
thalamus, newborn, donor10223	10366-105F6	5.75	9.21	5.75	2.88	4.03	4.03	1.73	0.00	0.58
throat, adult	10209-103G2	27.96	26.71	16.48	9.74	2.00	3.75	3.25	1.25	2.00
throat, fetal, donor1	10061-101H7	10.06	22.85	6.40	6.40	8.23	14.32	4.88	1.83	3.35
thymic carcinoma cell line:Ty-82	10803-111A2	3.38	3.78	2.98	1.59	0.40	0.99	0.99	0.40	0.20
thymus, adult, pool1	10027-101D9	0.99	2.09	5.27	1.39	4.27	1.29	1.19	0.00	3.58
thymus, fetal, pool1	10043-101F7	3.32	4.36	10.18	1.25	5.51	1.77	2.18	0.52	2.91
thyroid carcinoma cell line:KHM-5M	10776-110G2	13.03	13.69	5.32	3.72	2.53	4.25	3.99	1.33	0.93
thyroid carcinoma cell line:TCO-1	10783-110G9	2.51	10.34	3.49	1.40	2.24	4.61	3.91	0.56	0.14
thyroid, adult, pool1	10028-101E1	121.49	75.58	52.07	22.77	30.23	10.45	8.58	19.97	3.55
thyroid, fetal, donor1	10060-101H6	8.44	26.10	5.01	6.59	13.71	11.86	4.22	1.05	1.85
tongue epidermis (fungiform papillae), donor1	10288-104F9	33.88	24.64	18.48	6.16	9.24	6.16	9.24	3.08	3.08
tongue, adult	10203-103F5	6.98	9.07	4.88	4.19	1.86	1.63	1.40	1.16	1.86
tongue, fetal, donor1	10059-101H5	5.52	24.04	11.43	2.76	4.34	13.01	7.09	1.58	2.76
tonsil, adult, pool1	10047-101G2	9.72	7.61	9.22	1.20	6.31	2.30	3.01	1.30	2.40
trachea, adult, pool1	10029-101E2	24.95	15.71	18.08	4.58	9.49	6.13	4.17	1.88	5.32
trachea, fetal, donor1	10058-101H4	23.47	58.86	33.08	22.70	13.46	18.85	8.46	2.69	5.39
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	7.79	21.97	10.63	8.86	3.90	5.67	4.25	0.71	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	112.66	58.76	26.65	18.84	10.13	22.19	19.76	12.56	2.23
transitional-cell carcinoma cell line:JMSU1	10492-107B6	30.71	70.35	34.63	24.60	23.19	17.39	16.61	2.66	2.35
tridermal teratoma cell line:HGRT	10694-109G1	17.12	17.12	1.90	3.81	0.00	7.61	3.81	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	73.31	50.79	42.83	15.83	62.64	12.02	12.53	7.28	5.08
umbilical cord, fetal, donor1	10057-101H3	6.26	22.95	8.35	8.35	6.26	20.87	12.52	2.09	0.00
uterus, adult, pool1	10100-102D1	23.38	7.51	10.58	4.44	2.22	3.24	4.44	2.73	0.17
uterus, fetal, donor1	10055-101H1	30.72	60.41	17.92	17.92	6.14	32.25	11.77	6.14	2.05
vagina, adult	10204-103F6	19.39	8.40	15.51	3.88	5.82	1.29	0.65	2.58	3.23
vein, adult	10191-103E2	44.28	29.81	15.34	10.74	2.63	3.73	3.73	4.16	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	0.00	0.00	0.27	0.00	0.00	0.27	0.27	0.00	0.00